1
|
Clément G, Puisieux S, Pellerin D, Brais B, Bonnet C, Renaud M. Spinocerebellar ataxia 27B (SCA27B), a frequent late-onset cerebellar ataxia. Rev Neurol (Paris) 2024:S0035-3787(24)00486-7. [PMID: 38609751 DOI: 10.1016/j.neurol.2024.03.007] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/24/2024] [Revised: 03/18/2024] [Accepted: 03/25/2024] [Indexed: 04/14/2024]
Abstract
Genetic cerebellar ataxias are still a diagnostic challenge, and yet not all of them have been identified. Very recently, in early 2023, a new cause of late-onset cerebellar ataxia (LOCA) was identified, spinocerebellar ataxia 27B (SCA27B). This is an autosomal dominant ataxia due to a GAA expansion in intron 1 of the FGF14 gene. Thanks to the many studies carried out since its discovery, it is now possible to define the clinical phenotype, its particularities, and the progression of SCA27B. It has also been established that it is one of the most frequent causes of LOCA. The core phenotype of the disease consists of slowly progressive late-onset ataxia with cerebellar syndrome, oculomotor disorders including downbeat nystagmus, and episodic symptoms such as diplopia. Therapeutic approaches have been proposed, including acetazolamide, and 4-aminopyridine, the latter with a better benefit/tolerance profile.
Collapse
Affiliation(s)
- G Clément
- Service de neurologie, centre hospitalier régional universitaire de Nancy, hôpital Central, Nancy, France; Inserm-U1256 NGERE, université de Lorraine, Nancy, France.
| | - S Puisieux
- Service de neurologie, centre hospitalier régional universitaire de Nancy, hôpital Central, Nancy, France; Inserm-U1256 NGERE, université de Lorraine, Nancy, France.
| | - D Pellerin
- Department of Neurology and Neurosurgery, Montreal Neurological Hospital and Institute, McGill University, Montreal, QC, Canada; Dr. John T. Macdonald Foundation Department of Human Genetics and John P. Hussman Institute for Human Genomics, University of Miami Miller School of Medicine, Miami, USA.
| | - B Brais
- Department of Neurology and Neurosurgery, Montreal Neurological Hospital and Institute, McGill University, Montreal, QC, Canada.
| | - C Bonnet
- Inserm-U1256 NGERE, université de Lorraine, Nancy, France; Laboratoire de génétique, centre hospitalier régional universitaire de Nancy, hôpitaux de Brabois, Vandœuvre-lès-Nancy, France.
| | - M Renaud
- Service de neurologie, centre hospitalier régional universitaire de Nancy, hôpital Central, Nancy, France; Inserm-U1256 NGERE, université de Lorraine, Nancy, France; Service de génétique clinique, centre hospitalier régional universitaire de Nancy, hôpital d'Enfants, Vandœuvre-Lès-Nancy, France.
| |
Collapse
|
2
|
Renard E, Bonnet C, Di Patrizio M, Schmitt E, Madkaud AC, Chabot C, Kuchenbuch M, Lambert L. Megalencephaly secondary to a novel germline missense variant p.Asp322Tyr in AKT3 associated with growth hormone deficiency and central hypothyroidism: A case report. Am J Med Genet A 2024:e63585. [PMID: 38459620 DOI: 10.1002/ajmg.a.63585] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/11/2023] [Revised: 02/22/2024] [Accepted: 02/24/2024] [Indexed: 03/10/2024]
Abstract
Germline gain of function variations in the AKT3 gene cause brain overgrowth syndrome with megalencephaly and diffuse bilateral cortical malformations. Here we report a child with megalencephaly, who is a carrier of a novel heterozygous missense variant in the AKT3 gene NM_005465.7:c.964G>T,p.Asp322Tyr. The phenotype of this patient is associated with pituitary deficiencies diagnosed at 2 years of age: growth hormone (GH) deficiency responsible for growth delay and central hypothyroidism. After 6 months of GH treatment, intracranial hypertension was noted, confirmed by the observation of papilledema and increased intracranial pressure, requiring the initiation of acetazolamide treatment and the discontinuation of GH treatment. This is the second reported patient described with megalencephaly and AKT3 gene variant associated with GH deficiency . Other endocrine disorders have also been reported in few cases with hypothyroidism and hypoglycemia. Pituitary deficiency may be a part of the of megalencephaly phenotype secondary to germline variant in the AKT3 gene. Special attention should be paid to growth in these patients and search for endocrine deficiency is necessary in case of growth retardation or hypoglycemia.
Collapse
Affiliation(s)
- E Renard
- Pediatric Endocrinology Unit, Department of Pediatrics, University Hospital of Nancy, Nancy, France
- INSERM UMR_S 1256, Nutrition, Genetics, and Environmental Risk Exposure (NGERE), Faculty of Medicine of Nancy, University of Lorraine, Nancy, France
| | - C Bonnet
- INSERM UMR_S 1256, Nutrition, Genetics, and Environmental Risk Exposure (NGERE), Faculty of Medicine of Nancy, University of Lorraine, Nancy, France
- Genetics Laboratory, University Hospital of Nancy, Nancy, France
| | - M Di Patrizio
- Pediatric Endocrinology Unit, Department of Pediatrics, University Hospital of Nancy, Nancy, France
| | - E Schmitt
- Department of Neuroradiology, University Hospital of Nancy, Nancy, France
| | - A C Madkaud
- Department of Ophthalmology, University Hospital of Nancy, Nancy, France
| | - C Chabot
- Pediatric Endocrinology Unit, Department of Pediatrics, University Hospital of Nancy, Nancy, France
| | - M Kuchenbuch
- Department of Pediatric Neurology, University Hospital of Nancy, Nancy, France
- University of Lorraine, Nancy, France
| | - L Lambert
- INSERM UMR_S 1256, Nutrition, Genetics, and Environmental Risk Exposure (NGERE), Faculty of Medicine of Nancy, University of Lorraine, Nancy, France
- Department of Clinical Genetics, University Hospital of Nancy, Nancy, France
| |
Collapse
|
3
|
Blondel B, Beuzelin M, Bonnet C, Moreau C. Pregnancy intention and preconception contraceptive behaviors and substandard prenatal care in France. J Gynecol Obstet Hum Reprod 2023; 52:102608. [PMID: 37245644 DOI: 10.1016/j.jogoh.2023.102608] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/19/2023] [Revised: 05/25/2023] [Accepted: 05/26/2023] [Indexed: 05/30/2023]
Abstract
OBJECTIVE Evaluate the association between a combined measure of time-based pregnancy intention and preconception contraceptive behavior and suboptimal prenatal care. POPULATION AND METHOD Women delivering a live birth in all maternity units during one week in March 2016 were interviewed in the postpartum ward (N = 13,132). Multinomial logistic regression models were used to assess the association between the indicator of pregnancy intention and substandard prenatal care (late initiation of care and less than the recommended number of prenatal visits (<60% recommended)). RESULTS 83.6% of women had timed pregnancies, 4.7% had mistimed pregnancies but discontinued contraception to conceive, 8.0% had mistimed pregnancies without discontinuing contraception to conceive and 3.7% had unwanted pregnancies. Women with timed pregnancies or mistimed pregnancies despite discontinuing contraception to conceive were more socially advantaged than those who had an unwanted pregnancy or a mistimed pregnancy without discontinuing contraception to conceive. 3.3% of women had a substandard number of prenatal visits and 2.5% had delayed prenatal care initiation. The adjusted odds ratios (aOR) of substandard prenatal visits were high among women with unwanted pregnancies (aOR=2.78; 95% confidence interval [1.91-4.05]) and women with mistimed pregnancies who had not discontinued contraception to conceive (aOR=1.69; [1.21-2.35]) compared to women with timed pregnancies. No difference was observed for women with mistimed pregnancies who discontinued contraception to conceive (aOR=1.22; [0.70-2.12]). CONCLUSION Using routinely collected information on preconception contraception allows a more nuanced assessment of pregnancy intentions that can help caregivers identify women at greater risk of substandard prenatal care.
Collapse
Affiliation(s)
- Béatrice Blondel
- Obstetrical, Perinatal, and Pediatric Epidemiology Team (Epopé), Center of Research in Epidemiology and Statistics, Université Paris Cité, INSERM, 75014 Paris, France.
| | - Maxime Beuzelin
- Obstetrical, Perinatal, and Pediatric Epidemiology Team (Epopé), Center of Research in Epidemiology and Statistics, Université Paris Cité, INSERM, 75014 Paris, France
| | - Camille Bonnet
- Obstetrical, Perinatal, and Pediatric Epidemiology Team (Epopé), Center of Research in Epidemiology and Statistics, Université Paris Cité, INSERM, 75014 Paris, France
| | - Caroline Moreau
- Department of Population, Family and Reproductive Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA; Primary Care and Prevention, Centre for Research in Epidemiology and Population Health (CESP), U1018, INSERM, 94805 Villejuif, France
| |
Collapse
|
4
|
Bonnet C, Figoni J, Souty C, Septfons A, de Martino S, de Valk H, Fournier L, Hanslik T, Jaulhac B, Blanchon T. Prevalence and factors associated with a prescription of a Lyme borreliosis serology for erythema migrans diagnosis in general practice: a study from the French sentinel network, 2009-2020. BMC Prim Care 2023; 24:163. [PMID: 37620763 PMCID: PMC10464237 DOI: 10.1186/s12875-023-02108-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 06/14/2022] [Accepted: 07/18/2023] [Indexed: 08/26/2023]
Abstract
BACKGROUND Serological testing of patients consulting for typical erythema migrans (EM) is not recommended in European recommendations for diagnosis of Lyme borreliosis (LB). Little is known on the level of adherence of French general practitioners to these recommendations. The objectives were to estimate the proportion of Lyme borreliosis serological test prescription in patients with erythema migrans seen in general practice consultations in France, and to study the factors associated with this prescription. METHODS LB cases with an EM reported by the French general practitioners (GPs) of the Sentinelles network between January 2009 and December 2020 were included. To assess the associations with a prescription of a serological test, multilevel logistic regression models were used. RESULTS Among the 1,831 EM cases included, a prescription for a LB serological test was requested in 24.0% of cases. This proportion decreased significantly over the study period, from 46.8% in 2009 to 15.8% in 2020. A LB serological prescription was associated with patients with no reported tick bite (Odds Ratio (OR): 1.95; 95% confidence interval [1.23-3.09]), multiple EM (OR: 3.82 [1.63-8.92]), EM of five centimeters or more (OR: 4.34 [2.33-8.08]), and GPs having diagnosed less than one EM case per year during the study period (OR: 5.28 [1.73-16.11]). CONCLUSIONS Serological testing of patients consulting for EM is not recommended in European recommendations for diagnosis of Lyme borreliosis. Therefore, the significant decrease in the rate of LB serological test for EM over the study period is encouraging. The factors identified in this study can be used to improve messaging to GPs and patients. Further efforts are needed to continue to disseminate diagnostic recommendations for LB to GPs, especially those who rarely see patients with EM.
Collapse
Affiliation(s)
- Camille Bonnet
- Sorbonne Université, INSERM, Institut Pierre Louis d'Épidémiologie et de Santé Publique, IPLESP, Paris, F75012, France.
| | - Julie Figoni
- Santé publique France, Saint-Maurice, F94410, France
| | - Cécile Souty
- Sorbonne Université, INSERM, Institut Pierre Louis d'Épidémiologie et de Santé Publique, IPLESP, Paris, F75012, France
| | | | - Sylvie de Martino
- CNR des Borrelia et Institut de Bactériologie, Fédération de Médecine Translationnelle de Strasbourg, University of Strasbourg, CHRU Strasbourg, UR7290, ITI InnoVec, Strasbourg, 67000, France
| | | | - Lucie Fournier
- Sorbonne Université, INSERM, Institut Pierre Louis d'Épidémiologie et de Santé Publique, IPLESP, Paris, F75012, France
| | - Thomas Hanslik
- Sorbonne Université, INSERM, Institut Pierre Louis d'Épidémiologie et de Santé Publique, IPLESP, Paris, F75012, France
- Service de Médecine Interne, APHP, Hôpital Ambroise Paré, Assistance Publique - Hôpitaux de Paris, Boulogne-Billancourt, France
- Université Versailles Saint-Quentin-en-Yvelines, UVSQ, UFR de Médecine Simone Veil, Versailles, France
| | - Benoît Jaulhac
- CNR des Borrelia et Institut de Bactériologie, Fédération de Médecine Translationnelle de Strasbourg, University of Strasbourg, CHRU Strasbourg, UR7290, ITI InnoVec, Strasbourg, 67000, France
| | - Thierry Blanchon
- Sorbonne Université, INSERM, Institut Pierre Louis d'Épidémiologie et de Santé Publique, IPLESP, Paris, F75012, France
| |
Collapse
|
5
|
Grosyeux C, Jourdan L, Jellimann JM, Grandmougin A, Bronner M, Lambert L, Bonnet C. ENPP1 homozygous stop-loss variant causing generalized arterial cal cifications of infancy: About a severe neonatal clinical case. Eur J Med Genet 2023:104803. [PMID: 37379879 DOI: 10.1016/j.ejmg.2023.104803] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/13/2022] [Revised: 05/15/2023] [Accepted: 06/12/2023] [Indexed: 06/30/2023]
Abstract
Generalized Arterial Calcifications of Infancy (GACI) is an extremely rare autosomal recessive genetic condition, mostly due to pathogenic variations in the ENPP1 gene (GACI1, MIM # 208000, ENPP1, MIM *173335). To date 46 likely pathogenic or pathogenic distinct variations in ENPP1 have been described, including nonsense, frameshift, missense, splicing variations, and large deletions. Here we report a case of GACI in a male newborn with a homozygous stop-loss variant in ENPP1 treated in Nancy Regional University Maternity Hospital. Based on proband main clinical signs, clinical exome sequencing was performed and showed a deletion of one nucleotide leading to frameshift and stop-loss (NM_006208.3 (ENPP1):c.2746del,p.(Thr916Hisfs*23)). Clinical presentation is characterized by primary neonatal arterial hypertension resulting in hypertrophic cardiomyopathy decompensated by three cardiogenic shocks and a neonatal deep right sylvian stroke. The child died at 24 days of life. This is the first report of a pathogenic stop-loss variant in ENPP1. It is an opportunity to remind clinicians of GACI disease, a rare and severe etiology in neonates with severe hypertension, and possibility of bisphosphonates therapy.
Collapse
Affiliation(s)
- C Grosyeux
- : Soins Intensifs et Réanimation Néonatals, Pôle Enfants-néonatologie, Maternité régionale Universitaire, Nancy, France
| | - L Jourdan
- : Soins Intensifs et Réanimation Néonatals, Pôle Enfants-néonatologie, Maternité régionale Universitaire, Nancy, France
| | - J-M Jellimann
- : Soins Intensifs et Réanimation Néonatals, Pôle Enfants-néonatologie, Maternité régionale Universitaire, Nancy, France
| | - A Grandmougin
- : Service de radiologie, Hôpital d'enfants, CHRU de Nancy, France
| | - M Bronner
- : Laboratoire de Génétique, Pôle Laboratoires, CHRU de Nancy, France
| | - L Lambert
- : Inserm U1256, Université de Lorraine, France; : Service de Génétique Clinique, Pôle Enfants, CHRU de Nancy, France
| | - C Bonnet
- : Laboratoire de Génétique, Pôle Laboratoires, CHRU de Nancy, France; : Service de Génétique Clinique, Pôle Enfants, CHRU de Nancy, France.
| |
Collapse
|
6
|
Fu W, Bonnet C, Septfons A, Figoni J, Durand J, Frey-Klett P, Rustand D, Jaulhac B, Métras R. Spatial and seasonal determinants of Lyme borreliosis incidence in France, 2016 to 2021. Euro Surveill 2023; 28. [PMID: 37022210 DOI: 10.2807/1560-7917.es.2023.28.14.2200581] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 04/07/2023] Open
Abstract
BackgroundLyme borreliosis (LB) is the most widespread hard tick-borne zoonosis in the northern hemisphere. Existing studies in Europe have focused mainly on acarological risk assessment, with few investigations exploring human LB occurrence.AimWe explored the determinants of spatial and seasonal LB variations in France from 2016 to 2021 by integrating environmental, animal, meteorological and anthropogenic factors, and then mapped seasonal LB risk predictions.MethodsWe fitted 2016-19 LB national surveillance data to a two-part spatio-temporal statistical model. Spatial and temporal random effects were specified using a Besag-York-Mollie model and a seasonal model, respectively. Coefficients were estimated in a Bayesian framework using integrated nested Laplace approximation. Data from 2020-21 were used for model validation.ResultsA high vegetation index (≥ 0.6) was positively associated with seasonal LB presence, while the index of deer presence (> 60%), mild soil temperature (15-22 °C), moderate air saturation deficit (1.5-5 mmHg) and higher tick bite frequency were associated with increased incidence. Prediction maps show a higher risk of LB in spring and summer (April-September), with higher incidence in parts of eastern, midwestern and south-western France.ConclusionWe present a national level spatial assessment of seasonal LB occurrence in Europe, disentangling factors associated with the presence and increased incidence of LB. Our findings yield quantitative evidence for national public health agencies to plan targeted prevention campaigns to reduce LB burden, enhance surveillance and identify further data needs. This approach can be tested in other LB endemic areas.
Collapse
Affiliation(s)
- Wen Fu
- Sorbonne Université, INSERM, Institut Pierre Louis d'Épidémiologie et de Santé Publique, Paris, France
| | - Camille Bonnet
- Sorbonne Université, INSERM, Institut Pierre Louis d'Épidémiologie et de Santé Publique, Paris, France
| | | | | | - Jonas Durand
- Laboratoire Tous Chercheurs, Université de Lorraine, INRAE, UMR 1136 Interactions Arbres-Microorganismes, Nancy, France
| | - Pascale Frey-Klett
- Laboratoire Tous Chercheurs, Université de Lorraine, INRAE, UMR 1136 Interactions Arbres-Microorganismes, Nancy, France
| | - Denis Rustand
- Statistics Program, Computer, Electrical and Mathematical Sciences and Engineering Division, King Abdullah University of Science and Technology (KAUST), Thuwal, Saudi Arabia
| | - Benoît Jaulhac
- Institut de Bactériologie, Fédération de Médecine Translationnelle de Strasbourg, University of Strasbourg,ITI InnoVec, Strasbourg, France
- French National Reference Center for Borrelia, Hôpitaux Universitaires de Strasbourg, Strasbourg, France
| | - Raphaëlle Métras
- Department of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, United Kingdom
- Centre for Mathematical Modelling of Infectious Diseases, London School of Hygiene and Tropical Medicine, London, United Kingdom
- Sorbonne Université, INSERM, Institut Pierre Louis d'Épidémiologie et de Santé Publique, Paris, France
| |
Collapse
|
7
|
Bonnet C, Bayram M, El Bouzaïdi Tiali S, Lebon F, Harquel S, Palluel-Germain R, Perrone-Bertolotti M. Kinesthetic motor-imagery training improves performance on lexical-semantic access. PLoS One 2022; 17:e0270352. [PMID: 35749512 PMCID: PMC9232155 DOI: 10.1371/journal.pone.0270352] [Citation(s) in RCA: 4] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/04/2022] [Accepted: 06/08/2022] [Indexed: 11/30/2022] Open
Abstract
The objective of this study was to evaluate the effect of Motor Imagery (MI) training on language comprehension. In line with literature suggesting an intimate relationship between the language and the motor system, we proposed that a MI-training could improve language comprehension by facilitating lexico-semantic access. In two experiments, participants were assigned to a kinesthetic motor-imagery training (KMI) group, in which they had to imagine making upper-limb movements, or to a static visual imagery training (SVI) group, in which they had to mentally visualize pictures of landscapes. Differential impacts of both training protocols on two different language comprehension tasks (i.e., semantic categorization and sentence-picture matching task) were investigated. Experiment 1 showed that KMI training can induce better performance (shorter reaction times) than SVI training for the two language comprehension tasks, thus suggesting that a KMI-based motor activation can facilitate lexico-semantic access after only one training session. Experiment 2 aimed at replicating these results using a pre/post-training language assessment and a longer training period (four training sessions spread over four days). Although the improvement magnitude between pre- and post-training sessions was greater in the KMI group than in the SVI one on the semantic categorization task, the sentence-picture matching task tended to provide an opposite pattern of results. Overall, this series of experiments highlights for the first time that motor imagery can contribute to the improvement of lexical-semantic processing and could open new avenues on rehabilitation methods for language deficits.
Collapse
Affiliation(s)
- Camille Bonnet
- Univ. Grenoble Alpes, Univ. Savoie Mont Blanc, CNRS, LPNC, Grenoble, France
- Psychological Sciences Research Institute, Université Catholique de Louvain, Louvain-la-Neuve, Belgium
| | - Mariam Bayram
- Univ. Grenoble Alpes, Univ. Savoie Mont Blanc, CNRS, LPNC, Grenoble, France
| | | | - Florent Lebon
- INSERM UMR1093-CAPS, Université Bourgogne Franche-Comté, UFR des Sciences du Sport, Dijon, France
| | - Sylvain Harquel
- Univ. Grenoble Alpes, Univ. Savoie Mont Blanc, CNRS, LPNC, Grenoble, France
- Defitech Chair of Clinical Neuroengineering, Center for Neuroprosthetics (CNP) and Brain Mind Institute (BMI), Swiss Federal Institute of Technology Lausanne (EPFL), Campus Biotech, Geneva, Switzerland
| | | | - Marcela Perrone-Bertolotti
- Univ. Grenoble Alpes, Univ. Savoie Mont Blanc, CNRS, LPNC, Grenoble, France
- Institut Universitaire de France, Paris, France
- * E-mail:
| |
Collapse
|
8
|
Ruiz M, González S, Bonnet C, Deng SX. Extracellular miR-6723-5p could serve as a biomarker of limbal epithelial stem/progenitor cell population. Biomark Res 2022; 10:36. [PMID: 35642012 PMCID: PMC9153202 DOI: 10.1186/s40364-022-00384-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/27/2022] [Accepted: 05/16/2022] [Indexed: 11/12/2022] Open
Abstract
BACKGROUND Dysfunction or loss of limbal stem cells can result in limbal stem cell deficiency (LSCD), a disease that cause corneal opacity, pain, and loss of vision. Cultivated limbal epithelial transplantation (CLET) can be used to restore stem cell niche homeostasis and replenish the progenitor pool. Transplantation has been reported with high success rate, but there is an unmet need of prognostic markers that correlate with clinical outcomes. To date, the progenitor content in the graft is the only parameter that has been retrospectively linked to success. METHODS In this study, we investigate extracellular micro RNAs (miRNAs) associated with stem/progenitor cells in cultivated limbal epithelial cells (cLECs). Using micro RNA sequencing and linear regression modelling, we identify a miRNA signature in cultures containing high proportion of stem/progenitor cells. We then develop a robust RNA extraction workflow from culture media to confirm a positive miRNA correlation with stem/progenitor cell proportion. RESULTS miR-6723-5p is associated with cultures containing high proportion of stem/progenitor cells, and is detected in the basal layer of corneal epithelium. CONCLUSIONS These results indicate that miR-6723-5p could potentially serve as a stem/progenitor cell marker in cLECs.
Collapse
Affiliation(s)
- M. Ruiz
- Cornea Division, Stein Eye Institute, University of California, 100 Stein Plaza, Los Angeles, CA 90095 USA
| | - S. González
- Cornea Division, Stein Eye Institute, University of California, 100 Stein Plaza, Los Angeles, CA 90095 USA
| | - C. Bonnet
- Cornea Division, Stein Eye Institute, University of California, 100 Stein Plaza, Los Angeles, CA 90095 USA
- Cornea Department, Paris University, Cochin Hospital, AP-HP, F-75014 Paris, France
| | - S. X. Deng
- Cornea Division, Stein Eye Institute, University of California, 100 Stein Plaza, Los Angeles, CA 90095 USA
| |
Collapse
|
9
|
Amat L, Morel O, Diligent C, Bonnet C, Agopiantz M. [Systematic karyotyping before ICSI: A necessary procedure? Analysis of case studies in the Nancy University Hospital Fertility Centre]. Gynecol Obstet Fertil Senol 2022; 50:314-321. [PMID: 34990881 DOI: 10.1016/j.gofs.2021.12.012] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 08/10/2021] [Revised: 11/30/2021] [Accepted: 12/19/2021] [Indexed: 06/14/2023]
Abstract
INTRODUCTION A constitutional karyotype is often assayed for the couple before ICSI management. The objective of this study was to assess the prevalence of chromosomal abnormality in an infertile population, the impact on the care of couples and its cost. METHODS A single-center retrospective study was carried out at the Fertility Center of the University Hospital of Nancy, including all infertile couples who underwent a karyotype analysis from June 2009 to December 2016. RESULTS 1252 couples were included. 7.9% had at least one abnormal karyotype. A change in care affected 22% of these couples, i.e. 1.7% of the total population. 9% of couples with karyotype abnormality underwent PGD. In the male population, the percentage of abnormal spermograms is significantly higher in the group with karyotype abnormality compared to the control group (85.7% vs. 46.5%, P<0.001). DISCUSSION The constitutional karyotype, due to its high economic and human cost, and limited interest, is a screening method for chromosomal abnormalities that has no place systematically before performing IVF. The future lies in the restriction of the indications for prescribing the karyotype as well as in the realization of PGS in targeted situations.
Collapse
Affiliation(s)
- L Amat
- Service de médecine de la reproduction, CHRU de Nancy-site maternité, université de Lorraine, 10, rue du Dr-Heydenreich, 54000 Nancy, France; Service de gynécologie médicale, CHRU de Nancy, université de Lorraine, Nancy, France
| | - O Morel
- Service de gynécologie-obstétrique, CHRU de Nancy, université de Lorraine, Nancy, France
| | - C Diligent
- Laboratoire de biologie de la reproduction, CHRU de Nancy, université de Lorraine, Nancy, France
| | - C Bonnet
- Laboratoire de génétique, CHRU de Nancy, université de Lorraine, Vandœuvre-lès-Nancy, France; Inserm U1256, université de Lorraine, Vandœuvre-lès-Nancy, France
| | - M Agopiantz
- Service de médecine de la reproduction, CHRU de Nancy-site maternité, université de Lorraine, 10, rue du Dr-Heydenreich, 54000 Nancy, France; Inserm U1256, université de Lorraine, Vandœuvre-lès-Nancy, France.
| |
Collapse
|
10
|
Moreau C, Bonnet C, Beuzelin M, Blondel B. Pregnancy planning and acceptance and maternal psychological distress during pregnancy: results from the National Perinatal Survey, France, 2016. BMC Pregnancy Childbirth 2022; 22:162. [PMID: 35227224 PMCID: PMC8883609 DOI: 10.1186/s12884-022-04496-3] [Citation(s) in RCA: 10] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/26/2021] [Accepted: 02/10/2022] [Indexed: 11/16/2022] Open
Abstract
Background Studies report heightened risks of mental health problems among women who experience an unintended pregnancy, but few consider the complexity of pregnancy intentions. In this study, we evaluate how different dimensions of pregnancy intentions (pregnancy planning and pregnancy acceptance) relate to two maternal depressive symptoms and perceived psychological distress. Methods This study draws from a cross-sectional national survey conducted in all maternities in France over a one-week period in 2016. All mothers 18 years and older who had a live birth during the study period were invited to participate. After excluding women who underwent infertility treatment, our analytical sample included 10,339 women. We first described levels and correlates of pregnancy planning and acceptance, defined in four categories; planned/welcomed, unplanned/welcomed, planned/unwelcomed, unplanned/unwelcomed. We then assessed the bivariate and multivariate associations between pregnancy planning and acceptance and two outcomes: women’s self-perceived psychological health and the presence of two depressive symptoms during pregnancy. We used multivariate logistic regressions to evaluate these associations, after adjusting for socio-demographic and medical factors. Results Altogether 7.5 to 24.1% of mothers perceived their psychological health during pregnancy was poor, according to pregnancy planning and acceptance categories and 10.3 to 22.4% indicated feelings of sadness and loss of interest during pregnancy, according to pregnancy planning and acceptance categories. As compared to women with planned/welcomed pregnancies, the odds of perceived poor psychological health and depressive symptoms were 2.55 times (CI 2.20–2.95) and 1.75 times higher (CI 1.51–2.02), respectively, among unplanned/unwelcomed pregnancies and 2.02 (CI 1.61–2.53) and 2.07 (CI 1.7–2.5) higher, among planned/unwelcomed pregnancies. Among women with unplanned pregnancies, we also found higher odds of perceived poor psychological health among women whose pregnancy was unwelcomed while the odds of depressive symptoms were not different by pregnancy planning status among women with unwelcomed pregnancies. Conclusions These findings consolidate previous reports of the association between pregnancy intentions and maternal psychological distress, while further specifying the relationship, which mostly depends on the acceptance of pregnancy timing rather than on pregnancy planning. Identifying women with low pregnancy acceptance can potentially enhance current medical practice by improving early detection of maternal depression.
Collapse
Affiliation(s)
- Caroline Moreau
- Department of Population, Family and Reproductive Health, Johns Hopkins Bloomberg School of Public Health, 615 N Wolfe Street, Baltimore, MD, 21203, USA. .,Soins et Santé Primaire, CESP Centre for Research in Epidemiology and Population Health, U1018, INSERM, F-94805, Villejuif, France.
| | - Camille Bonnet
- Obstetrical, Perinatal and Pediatric Research Team, INSERM, Université de Paris, F-75014, Paris, France
| | - Maxime Beuzelin
- Obstetrical, Perinatal and Pediatric Research Team, INSERM, Université de Paris, F-75014, Paris, France
| | - Béatrice Blondel
- Obstetrical, Perinatal and Pediatric Research Team, INSERM, Université de Paris, F-75014, Paris, France
| |
Collapse
|
11
|
Salacroup C, David C, Fayemendy P, Misset B, Migolatiev M, Bonhommo S, Bonnet C, Calmel N, Charron L, Rouchaud A, Deluche E, Jésus P. Étude de la sarcopénie selon les critères de masse, de force et de fonction musculaire, au diagnostic de cancer du pancréas : impact sur la survie. NUTR CLIN METAB 2022. [DOI: 10.1016/j.nupar.2021.12.117] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
12
|
Merrer J, Le Ray C, Bonnet C, Coulm B, Blondel B. Overuse of antenatal visits and ultrasounds in low-risk women: A national population-based study. Paediatr Perinat Epidemiol 2021; 35:674-685. [PMID: 34160099 DOI: 10.1111/ppe.12782] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 12/17/2020] [Revised: 04/28/2021] [Accepted: 05/08/2021] [Indexed: 11/30/2022]
Abstract
BACKGROUND A better understanding of the overuse of antenatal care is needed to improve its organisation to deal with limited medical resources and doctor shortages. OBJECTIVES To assess the proportion of women who overuse antenatal care and the associations of overuse with maternal characteristics and the qualifications of healthcare providers. METHODS We used the 2016 National Perinatal Survey, a cross-sectional population-based survey, performed in all maternity units in France, including 13,132 women. Based on the French national guidelines, 6-8 antenatal visits were defined as adequate, 9-11 as high use, and ≥12 as overuse, while 3 ultrasounds were considered adequate, 4-5 as high use, and ≥6 as overuse. We performed binary modified Poisson regressions-with adequate care as the reference-including maternal social and medical characteristics and the healthcare professionals' qualifications. RESULTS After women with inadequate care were excluded, 19.2% of low-risk women had at least 12 visits and 30.5% at least 6 ultrasounds. Overuse of visits was associated with primiparity, average to high income, less than good psychological well-being, and care by an obstetrician. The risks of overuse of ultrasounds were higher among primiparous, women with average to high income and those receiving care from a public-sector obstetrician (adjusted relative risk 1.17, 95% CI, 1.13, 1.21) or private obstetrician (adjusted relative risk 1.12, 95% CI, 1.07, 1.16), compared with a public-sector midwife. CONCLUSIONS Antenatal care overuse is very common in France and associated with some maternal characteristics and also the qualification of care provider. Antenatal care should be customised according to women's needs, in particular for primiparae and those with poor well-being, and available medical resources.
Collapse
Affiliation(s)
- Jade Merrer
- Université de Paris/ Center of Research in Epidemiology and StatisticS(CRESS)/ Obstetrical Perinatal and Pediatric Epidemiology Research Team (EPOPé)/ INSERM/ INRA, Paris, France
| | - Camille Le Ray
- Université de Paris/ Center of Research in Epidemiology and StatisticS(CRESS)/ Obstetrical Perinatal and Pediatric Epidemiology Research Team (EPOPé)/ INSERM/ INRA, Paris, France.,Port-Royal Maternity Unit, Assistance Publique-Hôpitaux de Paris - Centre, Université de Paris, Paris, France
| | - Camille Bonnet
- Université de Paris/ Center of Research in Epidemiology and StatisticS(CRESS)/ Obstetrical Perinatal and Pediatric Epidemiology Research Team (EPOPé)/ INSERM/ INRA, Paris, France
| | - Bénédicte Coulm
- Université de Paris/ Center of Research in Epidemiology and StatisticS(CRESS)/ Obstetrical Perinatal and Pediatric Epidemiology Research Team (EPOPé)/ INSERM/ INRA, Paris, France
| | - Béatrice Blondel
- Université de Paris/ Center of Research in Epidemiology and StatisticS(CRESS)/ Obstetrical Perinatal and Pediatric Epidemiology Research Team (EPOPé)/ INSERM/ INRA, Paris, France
| |
Collapse
|
13
|
Simões J, Moran D, Edwards S, Bonnet C, Lopez-Sebastian A, Chemineau P. Editorial: Sustainable livestock systems for high producing animals. Animal 2021; 15 Suppl 1:100371. [PMID: 34688563 DOI: 10.1016/j.animal.2021.100371] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/22/2021] [Revised: 08/23/2021] [Accepted: 08/26/2021] [Indexed: 12/16/2022] Open
Affiliation(s)
- J Simões
- Departamento de Ciências Veterinárias, Universidade de Trás-os-Montes e Alto Douro, Quinta de Prados, 5000-801 Vila Real, Portugal.
| | - D Moran
- Global Academy of Agriculture and Food Security, The Royal (Dick) School of Veterinary Studies and The Roslin Institute, The University of Edinburgh, Easter Bush Campus, Midlothian EH25 9RG, United Kingdom
| | - S Edwards
- Newcastle Univ, School of Natural & Environmental Sciences, Newcastle Upon Tyne NE1 7RU, UK
| | - C Bonnet
- Toulouse School of Economics, INRAE, University of Toulouse I Capitole, 1 place de l'Université, 31080 Toulouse Cedex 6, France
| | - A Lopez-Sebastian
- Spanish Natl Inst Agr & Food Res & Technol INIA, Dept Anim Reprod, Madrid 28040, Spain
| | - P Chemineau
- UMR Physiologie de la Reproduction et des Comportements, INRAE, CNRS, IFCE, Université de Tours, 37380 Nouzilly, France; World Association of Animal Production (WAAP), Via Tomassetti, 3, 00161 Roma, Italy
| |
Collapse
|
14
|
Sebuhyan M, Crichi B, Deville L, Le Maignan C, Bonnet C, Marjanovic Z, Rueda J, Bensaoula O, Ndour A, Frere C, Madeleine I, Farge D. Patient education program at the forefront of cancer-associated thrombosis care. J Med Vasc 2021; 46:215-223. [PMID: 34862015 DOI: 10.1016/j.jdmv.2021.08.001] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 08/01/2021] [Accepted: 08/01/2021] [Indexed: 06/13/2023]
Abstract
INTRODUCTION Treatment of cancer-associated thrombosis (CAT) requires specific approaches, although it is well codified in most cases. Current national and international (International Initiative on Cancer and Thrombosis, ITAC) Clinical Practice Guidelines (CPG) recommend the use of low-molecular-weight heparin (LMWH) over 6 months as first treatment option, and anticoagulation should be maintained thereafter as long as cancer is active. Since compliance improves when patients understand their disease and related treatments, we created a dedicated patient education program (PEP) for CAT, aiming to improve quality of care. METHODS Retrospective analysis of all patients who voluntarily joined the PEP for CAT from 2014 to 2020. RESULTS In total, 182 cancer patients (median age, 64.9 years) were included, 53.3% with metastatic disease. A total of 528 PEP sessions (median, 3 per patient) were delivered. After PEP completion, the rate of self-injections or those performed at home by a relative had increased from 49.1% to 59.8% (P=0.05). Quality of life had improved significantly (P=0.025) and 90.0% of patients reported adhering to anticoagulant therapy. CONCLUSION Implementation of a structured and personalized PEP for CAT is feasible, allowing to improve cancer patient empowerment, adherence to CAT treatment and quality of life. The Groupe francophone et cancer (GFTC) members aim at facilitating access to CAT-PEP for both patients and caregivers and use of the multi-language ITAC-CPG mobile app (free access: www.itaccme.com) to improve the care and quality of life of patients with CAT.
Collapse
Affiliation(s)
- M Sebuhyan
- Groupe francophone thrombose et cancer, Paris, France; Department of Clinical Physiology, Lariboisière Hospital, AP-HP, Paris, France.
| | - B Crichi
- Groupe francophone thrombose et cancer, Paris, France; Department of Internal Medicine (UF 04), CRMR MATHEC, maladies auto-immunes et thérapie cellulaire, Saint-Louis Hospital, AP-HP, Paris, France
| | - L Deville
- Pharmacy Department, Saint-Louis Hospital, AP-HP, Paris, France
| | - C Le Maignan
- Groupe francophone thrombose et cancer, Paris, France; Department of Internal Medicine (UF 04), CRMR MATHEC, maladies auto-immunes et thérapie cellulaire, Saint-Louis Hospital, AP-HP, Paris, France
| | - C Bonnet
- Department of Medical Oncology, Saint-Louis Hospital, AP-HP, Paris, France
| | - Z Marjanovic
- Groupe francophone thrombose et cancer, Paris, France; Department of Hematology, Saint-Antoine Hospital, AP-HP, Paris, France
| | - J Rueda
- Groupe francophone thrombose et cancer, Paris, France; Department of Internal Medicine, Hospital Universitario Rey-Juan-Carlos, Madrid, Spain
| | - O Bensaoula
- Groupe francophone thrombose et cancer, Paris, France; Department of Medical Oncology CLCC Curie Institute, centre Rene-Huguenin, Saint Cloud, France
| | - A Ndour
- Groupe francophone thrombose et cancer, Paris, France; Department of Internal Medicine (UF 04), CRMR MATHEC, maladies auto-immunes et thérapie cellulaire, Saint-Louis Hospital, AP-HP, Paris, France
| | - C Frere
- Groupe francophone thrombose et cancer, Paris, France; Inserm UMRS_1166, Department of Hematology, Institute of Cardiometabolism And Nutrition, GRC 27 GRECO, Pitié-Salpêtrière Hospital, Sorbonne université, AP-HP, Paris, France
| | - I Madeleine
- Pharmacy Department, Saint-Louis Hospital, AP-HP, Paris, France
| | - D Farge
- Groupe francophone thrombose et cancer, Paris, France; Department of Internal Medicine (UF 04), CRMR MATHEC, maladies auto-immunes et thérapie cellulaire, Saint-Louis Hospital, AP-HP, Paris, France; EA 3518, institut universitaire d'hématologie, université de Paris, Paris, France.
| |
Collapse
|
15
|
Hazard A, Debin M, Hervé C, Guerrisi C, Bonnet C, François M. Implementation of a top five list to identify medical overuse in general practice according to patients' viewpoint in 2019 in France. BMC Fam Pract 2021; 22:134. [PMID: 34172006 PMCID: PMC8235619 DOI: 10.1186/s12875-021-01475-z] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 02/02/2021] [Accepted: 05/25/2021] [Indexed: 11/11/2022]
Abstract
BACKGROUND There is a current trend to reassess the adequacy of care. Establishing top five lists by involving patients is one way to address medical overuse. The objective of this study was to establish a patients' top five list in general practice in France. The secondary objective was to identify selection criteria. METHOD Patients from the web-based cohort GrippeNet.fr were invited to establish their top five list from 15 care procedures previously selected by general practitioners on the basis of medical overuse. The care procedures were presented on a web-interface with guides written with the help of a patient association. A questionnaire was used to explore factors that may have influenced the choices of the participants. RESULTS In total, 691 patients established the following top five list: 1/ Prescription of antibiotics for acute bronchitis, nasopharyngitis, otitis media with effusion, or uncomplicated influenza; 2/ Prescription of benzodiazepine and benzodiazepine-like agents for insomnia, generalised anxiety and all indications for older patients; 3/ Prescription of a homeopathic treatment (Influenzinum) for flu prevention; 4/ Prescription of antitussive or expectorant agents for acute cough or acute bronchitis care; 5/ Prescription of statins for the primary prevention of cardio-vascular risk in older patients. More than 70% of participants gave importance to the recommendations, effectiveness, and tolerance of the care procedures, whereas only half considered the cost. CONCLUSION This study is the first to establish a patient's top-five list in general practice. This list provides direction for deciding the main targets in limiting medical overuse.
Collapse
Affiliation(s)
- Agnès Hazard
- Department of Family Medicine, Faculty of Health Sciences Simone Veil, University Versailles-Saint-Quentin-en-Yvelines, Villejuif, Paris, France.
| | - Marion Debin
- Sorbonne Université, INSERM, Institut Pierre Louis D'Epidémiologie Et de Santé Publique, IPLESP F-75012, Paris, France
| | - Corentin Hervé
- Sorbonne Université, INSERM, Institut Pierre Louis D'Epidémiologie Et de Santé Publique, IPLESP F-75012, Paris, France
| | - Caroline Guerrisi
- Sorbonne Université, INSERM, Institut Pierre Louis D'Epidémiologie Et de Santé Publique, IPLESP F-75012, Paris, France
| | - Camille Bonnet
- Sorbonne Université, INSERM, Institut Pierre Louis D'Epidémiologie Et de Santé Publique, IPLESP F-75012, Paris, France
| | - Mathilde François
- Department of Family Medicine, Faculty of Health Sciences Simone Veil, University Versailles-Saint-Quentin-en-Yvelines, Villejuif, Paris, France
- Centre for Research in Epidemiology and Population Health, French National Institute of Health and Medical Research (INSERM U, University Versailles Saint-Quentin-en-Yvelines, University Paris-Sud, 1018), Villejuif, France
| |
Collapse
|
16
|
Sibon D, Bisig B, Bonnet C, Bachy E, Cavalieri D, Fataccioli V, Drieux F, Bruneau J, Lemonnier F, Bossard C, Bouabdallah K, Parrens M, Damaj G, Tournilhac O, Jais JP, Gaulard P, de Leval L. IMPACT OF DUSP22 REARRANGEMENT ON THE PROGNOSIS OF SYSTEMIC ALK‐NEGATIVE ANAPLASTIC LARGE CELL LYMPHOMA: A LYSA AND TENOMIC STUDY. Hematol Oncol 2021. [DOI: 10.1002/hon.137_2880] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
Affiliation(s)
- D Sibon
- Necker University Hospital, Hematology Paris France
| | - B Bisig
- Lausanne University Hospital, Pathology Lausanne Switzerland
| | - C Bonnet
- Liège University Hospital, Clinical Hematology Unit Liège Belgium
| | - E Bachy
- Lyon‐Sud University Hospital, Hematology Pierre‐Bénite France
| | - D Cavalieri
- Clermont‐Ferrand University Hospital, Hematology Clermont‐Ferrand France
| | - V Fataccioli
- Mondor University Hospital, Pathology Créteil France
| | - F Drieux
- Henri Becquerel Cancer Center, Pathology Rouen France
| | - J Bruneau
- Necker University Hospital, Pathology Paris France
| | - F Lemonnier
- Mondor University Hospital, Hematology Créteil France
| | - C Bossard
- Nantes University Hospital, Pathology Nantes France
| | - K Bouabdallah
- Haut‐Lévêque University Hospital, Hematology Bordeaux France
| | - M Parrens
- Haut‐Lévêque University Hospital, Pathology Bordeaux France
| | - G Damaj
- Caen University Hospital, Hematology Caen France
| | - O Tournilhac
- Clermont‐Ferrand University Hospital, Hematology Clermont‐Ferrand France
| | - J. P Jais
- Necker University Hospital, Statistics Paris France
| | - P Gaulard
- Mondor University Hospital, Pathology Créteil France
| | - L de Leval
- Lausanne University Hospital, Pathology Lausanne Switzerland
| |
Collapse
|
17
|
Bologna S, Vander Borght T, Briere J, Ribrag V, Damaj GL, Thieblemont C, Feugier P, Peyrade F, Lebras L, Coso D, Sibon D, Bonnet C, Morschhauser F, Ghesquieres H, Becker S, Olivier P, Fabiani B, Tilly H, Haioun C, Bastie JN. EARLY POSITRON EMISSION TOMOGRAPHY RESPONSE‐ADAPTED TREATMENT IN LOCALIZED DIFFUSE LARGE B‐CELL LYMPHOMA (AAIPI=0) : RESULTS OF THE PHASE 3 LYSA LNH 09‐1B TRIAL. Hematol Oncol 2021. [DOI: 10.1002/hon.5_2879] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Affiliation(s)
- S Bologna
- Hématologie Privée Nancéienne 54 Essey lès Nancy France
| | | | - J Briere
- CHU Henri Mondor 94 Créteil France
| | - V Ribrag
- Institut Gustave Roussy 94 Villejuif France
| | | | | | - P Feugier
- CHRU Nancy 54 Vandoeuvre lès Nancy France
| | - F Peyrade
- Centre Antoine Lacassagne 06 Nice France
| | - L Lebras
- Centre Léon Berard 69 Lyon, France
| | - D Coso
- Institut Paoli Calmette 13 Marseille France
| | - D Sibon
- Hôpital Necker-Enfants Malades 75 Paris France
| | | | | | | | - S Becker
- Centre Henri Becquerel 76 Rouen France
| | - P Olivier
- CHRU Nancy 54 Vandoeuvre lès Nancy France
| | - B Fabiani
- Hopital Saint Antoine 75 Paris France
| | - H Tilly
- Centre Henry Becquerel 76 Rouen France
| | - C Haioun
- Hopital Henri Mondor 94 Créteil France
| | | |
Collapse
|
18
|
Cavalieri D, Tournilhac O, Missiglia E, Bonnet C, Ledoux‐Pilon A, Bisig B, Cairoli A, Poullot E, Fataccioli V, Parrens M, Copin MC, Gutierrez FL, Xerri L, Bossard C, Wind R, Drieux F, Lhomme F, Daniel A, Clément‐Filliatre L, Lemmonier F, Morel P, Noël R, Brotelle T, Glaisner S, Sibon D, Yamani A, Bologna S, Queru K, Damaj G, Letailleur V, Villemagne B, Fleck E, Dupont E, Tchernonog E, Monjanel H, Wilde V, Vallois D, Gaulard P, Leval L. MONOMORPHIC EPITHELIOTROPIC INTESTINAL T‐CELL LYMPHOMA (MEITL): CLINICO‐PATHOLOGICAL ANALYSIS OF A MULTICENTER EUROPEAN COHORT. Hematol Oncol 2021. [DOI: 10.1002/hon.44_2879] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
|
19
|
Hübel K, Scholz CW, Luminari S, Salar A, Wahlin BE, Gopal AK, Bonnet C, Trneny M, Paneesha S, Manzke O, Seguy F, Li D, Sehn LH. INMIND: A PHASE 3 STUDY OF TAFASITAMAB + LENALIDOMIDE AND RITUXIMAB VS PLACEBO + LENALIDOMIDE AND RITUXIMAB FOR RELAPSED/REFRACTORY FOLLICULAR OR MARGINAL ZONE LYMPHOMA. Hematol Oncol 2021. [DOI: 10.1002/hon.175_2880] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
Affiliation(s)
- K. Hübel
- University Hospital Cologne Department of Internal Medicine I Oncology and Hematology Cologne Germany
| | - C. W. Scholz
- Vivantes Klinikum Am Urban Department of Hematology and Oncology Berlin Germany
| | - S. Luminari
- Azienda USL‐IRCCS di Reggio Emilia Hematology Unit Reggio Emilia Italy
| | - A. Salar
- Hospital del Mar‐IMIM Department of Haematology Barcelona Spain
| | - B. E. Wahlin
- Unit of Hematology Karolinska Institute Department of Medicine Stockholm Sweden
| | - A. K. Gopal
- University of Washington Medicine Division of Medical Oncology Seattle Washington USA
| | - C. Bonnet
- Centre Hospitalier Universitaire University of Liège Clinical Hematology Liège Belgium
| | - M. Trneny
- First Faculty of Medicine Charles University General Hospital First Department of Medicine Prague Czech Republic
| | - S. Paneesha
- University Hospitals Birmingham NHS Foundation Trust Hematology Birmingham UK
| | - O. Manzke
- Incyte Biosciences International Sàrl Clinical Development Morgues Switzerland
| | - F. Seguy
- Incyte Biosciences International Sàrl Clinical Development Morgues Switzerland
| | - D. Li
- Incyte Corporation Biostatistics Wilmington Delaware USA
| | - L. H. Sehn
- BC Cancer Centre for Lymphoid Cancer and The University of British Columbia Division of Medical Oncology Vancouver Canada
| |
Collapse
|
20
|
Camus V, Rossi C, Sesques P, Lequesne J, Tonnelet D, Haioun C, Durot E, Willaume A, Gauthier M, Moles‐Moreau M, Antier C, Lazarovici J, Monjanel H, Bernard S, Tardy M, Besson C, Lebras L, Choquet S, Le Du K, Bonnet C, Bailly S, Damaj G, Laribi K, Maisonneuve H, Houot R, Chauchet A, Jardin F, Traverse‐Glehen A, Decazes P, Becker S, Berriolo‐Riedinger A, Tilly H. OUTCOMES AFTER FIRST‐LINE IMMUNOCHEMOTHERAPY FOR PRIMARY MEDIASTINAL B CELL LYMPHOMA PATIENTS: A LYSA STUDY. Hematol Oncol 2021. [DOI: 10.1002/hon.50_2879] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
Affiliation(s)
- V. Camus
- Centre Henri Becquerel Department of Hematology Rouen France
| | - C. Rossi
- Dijon University Hospital Hematology Dijon France
| | - P. Sesques
- CHU Lyon Sud, Hematology Pierre‐Bénite France
| | - J. Lequesne
- Centre Henri Becquerel Clinical Research Unit Rouen France
| | - D. Tonnelet
- Centre Henri Becquerel Department of Nuclear Medicine Rouen France
| | - C. Haioun
- CHU Mondor, Hematology Créteil France
| | - E. Durot
- CHU Reims Hematology Reims France
| | | | | | | | | | | | | | | | - M. Tardy
- Centre Antoine Lacassagne Hematology Nice France
| | - C. Besson
- Centre Hospitalier de Versailles Hematology Le Chesnay France
| | - L. Lebras
- Centre Leon Berard Hematology Lyon France
| | - S. Choquet
- CHU La pitié salpetriere Hematology Paris France
| | - K. Le Du
- Clinique Victor Hugo Hematology Le Mans France
| | - C. Bonnet
- Liege University Hospital Hematology Liege Belgium
| | - S. Bailly
- Cliniques Universitaires Saint Luc Hematology Bruxelles Belgium
| | | | - K. Laribi
- CH Le Mans Hematology Le Mans France
| | - H. Maisonneuve
- CH Departemental de Vendée Hematology la Roche sur Yon France
| | - R. Houot
- CHU Rennes Hematology Rennes France
| | | | - F. Jardin
- Centre Henri Becquerel Department of Hematology Rouen France
| | | | - P. Decazes
- Centre Henri Becquerel Department of Nuclear Medicine Rouen France
| | - S. Becker
- Centre Henri Becquerel Department of Nuclear Medicine Rouen France
| | | | - H. Tilly
- Centre Henri Becquerel Department of Hematology Rouen France
| |
Collapse
|
21
|
Gastinne T, Bouabdallah K, Moatti H, Tessoulin B, Shiano del colella JM, Lamy T, Casasnovas O, Borel C, Stamatoullas A, Gac AC, Chaoui D, Feugier P, Delmer A, Bonnet C, Fornecker L, Lazarovici J, Bras F, Ghesquieres H, Meignan M, Traverse Glehen A, Brice P. BRENTUXIMAB VEDOTIN AS CONSOLIDATION TREATMENT IN PATIENTS WITH STAGE I/II CLASSICAL HODGKIN'S LYMPHOMA AND A POSITIVE FDG‐PET AFTER 2 CYCLES OF ABVD: A LYSA PHASE 2 STUDY. Hematol Oncol 2021. [DOI: 10.1002/hon.111_2880] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Affiliation(s)
- T. Gastinne
- University Hospital of Nantes Hematology Nantes France
| | - K. Bouabdallah
- Hopital Haut‐Levêque Centre Hospitalier Regional Universitaire de Bordeaux Department of Hematology Pessac France
| | - H. Moatti
- Hôpital saint Louis APHP Université Paris 7 Department of Oncohaematology Paris France
| | - B. Tessoulin
- University Hospital of Nantes Hematology Nantes France
| | | | - T. Lamy
- Rennes University Hospital Department of Clinical Hematology MICA Research Unit Rennes France
| | - O. Casasnovas
- University Hospital F Mitterrand and INSERM 1231 Department of Haematology Dijon France
| | - C. Borel
- IUCT‐Oncopole CHU Toulouse Department of Haematology Toulouse France
| | - A. Stamatoullas
- Centre Henri Becquerel Department of Haematology U918 Rouen France
| | - A. C. Gac
- Centre Hospitalier Universitaire de Caen Institut d'hématologie de Basse‐Normandie Caen France
| | - D. Chaoui
- Centre Hospitalier d'Argenteuil Department of Hematology Argenteuil France
| | - P. Feugier
- Nancy University Hospital Department of Clinical Hematology INSERM 1256 Nancy France
| | - A. Delmer
- University Hospital of Reims Department of Haematology Reims France
| | - C. Bonnet
- CHU Liège, Liège Université Campus Universitaire de Sart Tilman Clinical Hematology Unit Liège Belgium
| | - Luc‐M. Fornecker
- Strasbourg University Hospital Department of Clinical Hematology Strasbourg France
| | - J. Lazarovici
- Institut Gustave Roussy Département des Innovations Thérapeutiques et Essais Précoces Villejuif France
| | - F. Bras
- CHU Henri Mondor Department of Hematology Creteil France
| | - H. Ghesquieres
- Hospices Civils de Lyon Centre Hospitalier Lyon‐Sud and Université Claude Bernard Lyon‐1 Department of Haematology Lyon France
| | - M. Meignan
- Hôpital H Mondor LYSA Imaging Creteil France
| | - A. Traverse Glehen
- Centre Hospitalier Lyon‐Sud Hospices Civils de Lyon Pathology Department cedex, France, Lyon France
| | - P. Brice
- Hôpital saint Louis APHP Université Paris 7 Department of Oncohaematology Paris France
| |
Collapse
|
22
|
Fossard G, Broussais F, Coelho I, Bailly S, Nicolas-Virelizier E, Toussaint E, Lancesseur C, Le Bras F, Willems E, Tchernonog E, Chalopin T, Delarue R, Gressin R, Chauchet A, Gyan E, Cartron G, Bonnet C, Haioun C, Damaj G, Gaulard P, Fornecker L, Ghesquières H, Tournilhac O, Gomesda Silva M, Bouabdallah R, Salles G, Bachy E. Corrigendum to 'Role of up-front autologous stem-cell transplantation in peripheral T-cell lymphoma for patients in response after induction: an analysis of patients from LYSA centers': [Annals of Oncology Volume 29, Issue 3, March 2018, Pages 715-723]. Ann Oncol 2021; 32:945. [PMID: 33992519 DOI: 10.1016/j.annonc.2021.04.021] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022] Open
Affiliation(s)
- G Fossard
- Hematology Department, CHU Lyon Sud, Hospices Civils de Lyon, Pierre Benite, France; Claude Bernard Lyon 1 University, Lyon, France; Cancer Center of Lyon (CRCL), INSERM U1052 - CNRS UMR5286, Lyon, France
| | - F Broussais
- Hematology Department, CHU Lyon Sud, Hospices Civils de Lyon, Pierre Benite, France
| | - I Coelho
- Hematology Department, Portuguese Institute of Oncology, Lisbon, Portugal
| | - S Bailly
- Hematology and Cell Therapy Department, Hôpital Estaing, CHU de Clermont-Ferrand, Clermont-Ferrand, France; Clermont Auvergne University, Clermont-Ferrand, France
| | | | - E Toussaint
- Hematology Department, CHU de Strasbourg, Strasbourg, France
| | | | - F Le Bras
- Hematology Department, CHU Henri Mondor, Creteil, France
| | - E Willems
- Hematology Department, CHU de Liège, Liège, Belgium
| | - E Tchernonog
- Hematology Department, CHU de Montpellier, Montpellier, France
| | - T Chalopin
- Hematology Department, CHU de Tours, Tours, France
| | - R Delarue
- Hematology Department, CHU Necker Enfants Malades, AP-HP, Paris, France
| | - R Gressin
- Hematology Department, CHU de Grenoble, Grenoble, France
| | - A Chauchet
- Hematology Department, CHU de Besançon, Besançon, France
| | - E Gyan
- Hematology Department, CHU de Tours, Tours, France
| | - G Cartron
- Hematology Department, CHU de Montpellier, Montpellier, France
| | - C Bonnet
- Hematology Department, CHU de Liège, Liège, Belgium
| | - C Haioun
- Hematology Department, CHU Henri Mondor, Creteil, France
| | - G Damaj
- Hematology Institute, CHU de Caen, Caen, France
| | - P Gaulard
- Hematology Department, CHU Henri Mondor, Creteil, France
| | - L Fornecker
- Hematology Department, CHU de Strasbourg, Strasbourg, France
| | - H Ghesquières
- Hematology Department, CHU Lyon Sud, Hospices Civils de Lyon, Pierre Benite, France
| | - O Tournilhac
- Hematology and Cell Therapy Department, Hôpital Estaing, CHU de Clermont-Ferrand, Clermont-Ferrand, France; Clermont Auvergne University, Clermont-Ferrand, France
| | - M Gomesda Silva
- Hematology Department, Portuguese Institute of Oncology, Lisbon, Portugal
| | - R Bouabdallah
- Hematology Department, Institut Paoli Calmette, Marseille, France
| | - G Salles
- Hematology Department, CHU Lyon Sud, Hospices Civils de Lyon, Pierre Benite, France; Claude Bernard Lyon 1 University, Lyon, France; Cancer Center of Lyon (CRCL), INSERM U1052 - CNRS UMR5286, Lyon, France
| | - E Bachy
- Hematology Department, CHU Lyon Sud, Hospices Civils de Lyon, Pierre Benite, France; Claude Bernard Lyon 1 University, Lyon, France; Cancer Center of Lyon (CRCL), INSERM U1052 - CNRS UMR5286, Lyon, France.
| |
Collapse
|
23
|
Maquet C, Beguin Y, De Prijck B, Willems E, Servais S, Bonnet C. [Diffuse large B-cell lymphoma: a revolutionary treatment based on genetically-modified immune cells called CAR T cells]. Rev Med Liege 2021; 76:476-481. [PMID: 34080383] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/12/2023]
Abstract
Diffuse large B-cell lymphoma (DLBCL) is the most common subtype of non-Hodgkin lymphoma. Firstline immunochemotherapy cures approximatively 60 % of patients. The prognosis of patients with refractory disease or with relapsed disease within the first two years after the end of treatment is highly unfavourable. Since June 2019, a new third-line treatment with CAR T cells (chimeric antigen receptor T cells) seems to completely modify the prognosis of these patients. A significant proportion of long-lasting complete responses is obtained with this revolutionary treatment. Quick specialized intervention is required for the unique side effects of this therapy.
Collapse
Affiliation(s)
- C Maquet
- Service d'Hématologie, CHU Liège, Belgique
| | - Y Beguin
- Service d'Hématologie, CHU Liège, Belgique
| | | | - E Willems
- Service d'Hématologie, CHU Liège, Belgique
| | - S Servais
- Service d'Hématologie, CHU Liège, Belgique
| | - C Bonnet
- Service d'Hématologie, CHU Liège, Belgique
| |
Collapse
|
24
|
Fu W, Bonnet C, Figoni J, Septfons A, Métras R. Exploratory Space-Time Analyses of Reported Lyme Borreliosis Cases in France, 2016-2019. Pathogens 2021; 10:pathogens10040444. [PMID: 33917723 PMCID: PMC8068173 DOI: 10.3390/pathogens10040444] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/02/2021] [Revised: 04/02/2021] [Accepted: 04/04/2021] [Indexed: 12/18/2022] Open
Abstract
In recent decades, the incidence of Lyme borreliosis (LB) in Europe seems to have increased, underpinning a growing public health concern. LB surveillance systems across the continent are heterogeneous, and the spatial and temporal patterns of LB reports have been little documented. In this study, we explored the spatio-temporal patterns of LB cases reported in France from 2016 to 2019, to describe high-risk clusters and generate hypotheses on their occurrence. The space–time K-function and the Kulldorf’s scan statistic were implemented separately for each year to evaluate space–time interaction between reported cases and searching clusters. The results show that the main spatial clusters, of radius size up to 97 km, were reported in central and northeastern France each year. In 2017–2019, spatial clusters were also identified in more southern areas (near the Alps and the Mediterranean coast). Spatio-temporal clustering occurred between May and August, over one-month to three-month windows in 2016–2017 and in 2018–2019. A strong spatio-temporal interaction was identified in 2018 within 16 km and seven days, suggesting a potential local and intense pathogen transmission process. Ongoing improved surveillance and accounting for animal hosts, vectors, meteorological factors and human behaviors are keys to further elucidate LB spatio-temporal patterns.
Collapse
Affiliation(s)
- Wen Fu
- Sorbonne Université, INSERM, Institut Pierre Louis d’Épidémiologie et de Santé Publique, F75012 Paris, France; (C.B.); (R.M.)
- Correspondence:
| | - Camille Bonnet
- Sorbonne Université, INSERM, Institut Pierre Louis d’Épidémiologie et de Santé Publique, F75012 Paris, France; (C.B.); (R.M.)
| | - Julie Figoni
- Santé publique France, F94410 Saint-Maurice, France; (J.F.); (A.S.)
| | | | - Raphaëlle Métras
- Sorbonne Université, INSERM, Institut Pierre Louis d’Épidémiologie et de Santé Publique, F75012 Paris, France; (C.B.); (R.M.)
| |
Collapse
|
25
|
Lebas E, Collins P, Bonnet C, Libon F, Dezfoulian B, Nikkels AF. [Management of mycosis fungoide : focus on brentuximab vedotin]. Rev Med Liege 2021; 76:224-231. [PMID: 33830684] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/12/2023]
Abstract
Recently, brentuximab vedotin (BV) (Adcetris®) obtained the reimbursement in Belgium for the treatment of the primary cutaneous NKT-cell lymphomas mycosis fungoides (MF), large cell anaplastic lymphoma and lymphomatoid papulosis type A. BV is a monoclonal antibody directed against the CD30 expressed on tumoral T cells. The inhibition of this pathway releases the process of apoptosis leading to the cell death of the tumoral cells. BV is reimbursed after the use of another systemic treatment without success and if the number of CD30 positive atypical T-cells is larger than 10 %. BV is administered intravenously every 3 weeks with a dosing of 1,8 mg/kg with a maximum of 16 courses. The response rates exceed 75 %. In some instances, interesting treatment responses have been observed with BV in CD30 negative patients. The principal adverse effects are neutropenia and peripheral neuropathy. Two patients are presented with longstanding multi-resistant MF that were successfully treated with BV.
Collapse
Affiliation(s)
- E Lebas
- ) Service de Dermatologie, CHU Liège, Belgique
| | - P Collins
- Service de Dermatopathologie, CHU Liège, Belgique
| | - C Bonnet
- Service d'Hématologie, CHU Liège, Belgique
| | - F Libon
- ) Service de Dermatologie, CHU Liège, Belgique
| | | | - A F Nikkels
- ) Service de Dermatologie, CHU Liège, Belgique
| |
Collapse
|
26
|
Demiguel V, Blondel B, Bonnet C, Nguyen-Thanh V, Saurel-Cubizolles MJ, Regnault N. Trends in Tobacco Smoking in Pregnant Women: Data From French National Perinatal Surveys. Int J Public Health 2021; 66:602873. [PMID: 34744568 PMCID: PMC8565271 DOI: 10.3389/ijph.2021.602873] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/04/2020] [Accepted: 02/11/2021] [Indexed: 01/04/2023] Open
Abstract
Objectives: To describe maternal smoking trends in France between 1972 and 2016, and identify whether maternal characteristics associated with smoking in the 3rd trimester of pregnancy evolved between 2010 and 2016. Methods: Using French National Perinatal Surveys, we estimated proportions of smokers and the number of cigarettes smoked both just before pregnancy and during the 3rd trimester from 1972 to 2016. We used a Poisson model with robust variance to estimate prevalence ratios for smoking during pregnancy. Results: Proportions of mothers quitting smoking were relatively stable (46.0% in 1972 and 45.8% in 2016). The number of cigarettes smoked just before pregnancy and in the 3rd trimester decreased from 1995 onward. However, proportions of smokers remained high before (30.1%) and during the 3rd trimester in 2016 (16.2%). Smoking in the 3rd trimester was associated with a lower education level and lower income in both 2010 and 2016, whereas the association with age, country of birth and parity varied according to the survey year. Conclusion: Early targeted interventions are needed for smokers who plan to have a child and must take smokers' characteristics during pregnancy into account.
Collapse
Affiliation(s)
- Virginie Demiguel
- Santé Publique France, French National Public Health Agency, Saint-Maurice, France
| | - Béatrice Blondel
- Université de Paris, CRESS, INSERM, INRA, Paris, France
- INSERM U1153, Obstetrical, Perinatal and Paediatric Epidemiology Research Team (Epopé), Paris, France
| | - Camille Bonnet
- Université de Paris, CRESS, INSERM, INRA, Paris, France
- INSERM U1153, Obstetrical, Perinatal and Paediatric Epidemiology Research Team (Epopé), Paris, France
| | - Viêt Nguyen-Thanh
- Santé Publique France, French National Public Health Agency, Saint-Maurice, France
| | - Marie-Josèphe Saurel-Cubizolles
- Université de Paris, CRESS, INSERM, INRA, Paris, France
- INSERM U1153, Obstetrical, Perinatal and Paediatric Epidemiology Research Team (Epopé), Paris, France
| | - Nolwenn Regnault
- Santé Publique France, French National Public Health Agency, Saint-Maurice, France
| |
Collapse
|
27
|
Bonnet C, Blondel B, Moreau C. A rise in births following contraceptive failure in France between 2010 and 2016: results from the French national perinatal surveys. BMC Womens Health 2021; 21:115. [PMID: 33743652 PMCID: PMC7981992 DOI: 10.1186/s12905-021-01255-y] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 03/10/2020] [Accepted: 03/08/2021] [Indexed: 11/17/2022]
Abstract
Background In France, while the prevalence of contraception is high, a significant proportion of pregnancies are unintended. Following the 2012 pill scare, the contraceptive method mix, which was mostly comprised of pills and intrauterine devices (IUD), has become more diversified. In this changing landscape, our objective was to describe trends in live births resulting from contraceptive failure and evaluate how patterns of contraceptive use have contributed to observed changes between 2010 and 2016. Methods We used data from the 2010 and the 2016 French National Perinatal surveys which included all births from all maternity units in France over a one-week period. Interviews collecting information about pre-conception contraceptive practices were conducted in the maternity ward post-delivery. Women were classified as having a contraceptive failure if they discontinued contraception because they were pregnant. Our study sample included adult women who had a live birth, had ever used contraception and did not undergo infertility treatment (n = 11,590 in 2010 and n = 9703 in 2016). We evaluated changes in contraceptive failure over time using multivariate Poisson regressions to adjust for sociodemographic characteristics and pre-pregnancy contraceptive methods. Results Pre-pregnancy contraception evolved between 2010 and 2016 with a 12.3% point-drop in pill use, and conversely, 4.6%- and 3.2%-point increases in IUD and condom use, respectively. Use of other barrier or natural methods doubled between 2010 and 2016 but remained marginal (1.4% in 2010 vs 3.6% in 2016). Between 2010 and 2016, the proportion of live births resulting from contraceptive failure rose from 7.8 to 10.0%, with higher risks among younger, parous and socially disadvantaged mothers. The risk ratio of contraceptive failure in 2016 compared to 2010 remained higher after sociodemographic adjustments (aRR = 1.34; 95% CI; 1.23–1.47) and after adjusting for pre-pregnancy contraceptive method mix (aRR = 1.35; 95% CI; 1.25–1.49). Increases in contraceptive failures were concentrated among pill and condom users. Conclusions Recent shifts in contraceptive behaviors in France following the 2012 pill scare may be associated with a subsequent increase in births resulting from short acting contraceptives failures. Supplementary Information The online version contains supplementary material available at 10.1186/s12905-021-01255-y.
Collapse
Affiliation(s)
- Camille Bonnet
- Obstetrical, Perinatal and Pediatric Epidemiology Research Team (Epopé), Center for Epidemiology and Statistics, INSERM, Université de Paris, Maternité Port Royal, 123, Boulevard Port Royal, 75014, Paris, France
| | - Béatrice Blondel
- Obstetrical, Perinatal and Pediatric Epidemiology Research Team (Epopé), Center for Epidemiology and Statistics, INSERM, Université de Paris, Maternité Port Royal, 123, Boulevard Port Royal, 75014, Paris, France.
| | - Caroline Moreau
- Department of Population, Family and Reproductive Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.,Primary Care and Prevention, Centre for Research in Epidemiology and Population Health (CESP), U1018, INSERM, Villejuif, France
| |
Collapse
|
28
|
Enjary M, Monnet D, Bonnet C, Brézin AP. Patients' perception of the open-space operating hall for cataract surgery. J Fr Ophtalmol 2021; 44:494-498. [PMID: 33736858 DOI: 10.1016/j.jfo.2020.06.043] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/03/2020] [Accepted: 06/23/2020] [Indexed: 11/18/2022]
Abstract
PURPOSE To assess the perception of patients undergoing cataract surgery under topical anesthesia in an open-space operating hall. METHODS The study was set in the department of ophthalmology, Cochin Paris Descartes University Hospital, in a newly built open-space operating hall dedicated to ophthalmic surgery. It was a prospective study of consecutive patients undergoing cataract surgery by 11 surgeons. Our population study comprised 250 patients operated in an open-space operating hall with 3 surgical areas. Only first-eye standard cataract surgeries performed under topical anesthesia were included. Responses to a face-to-face questionnaire administered by a single interviewer to patients before their discharge on the day of their surgery were analyzed. RESULTS Fifty-two patients (21%) knew beforehand that their procedure would take place in an open-space operating hall, 118 (47%) realized that they were in such an environment on the occasion of their surgery and 80 (32%) did not notice. Conversations and noises unrelated to their own surgeries were overheard respectively by 15 (6%) and 37 (15%) patients. Of the 250 patients, 237 (95%) did not report any discomfort associated with the fact that their procedure had been performed in an open-space operating hall. CONCLUSIONS Cataract surgery performed in an open-space setting did not seem to affect the patients' comfort during the procedure.
Collapse
Affiliation(s)
- M Enjary
- Service d'ophtalmologie, hôpital Cochin, université Paris-Descartes, 27, rue du Faubourg-Saint-Jacques, 75014 Paris, France
| | - D Monnet
- Service d'ophtalmologie, hôpital Cochin, université Paris-Descartes, 27, rue du Faubourg-Saint-Jacques, 75014 Paris, France
| | - C Bonnet
- Service d'ophtalmologie, hôpital Cochin, université Paris-Descartes, 27, rue du Faubourg-Saint-Jacques, 75014 Paris, France
| | - A P Brézin
- Service d'ophtalmologie, hôpital Cochin, université Paris-Descartes, 27, rue du Faubourg-Saint-Jacques, 75014 Paris, France.
| |
Collapse
|
29
|
Radermecker A, Bonnet C, Lutteri L, Chapelle AC, Petignot S, Lievens I, Caers J. [An illustrative case of the POEMS syndrome]. Rev Med Liege 2021; 76:156-159. [PMID: 33682383] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/12/2023]
Abstract
POEMS syndrome is a rare and invalidating entity characterized by polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy and dermatoses. The diagnosis of this condition is often late and challenging due to the heterogeneity of clinical forms. The light chains secreted by the clonal plasmocytes cause overproduction of VEGF (Vascular Endothelial Growth Factor) responsible for the appearance of the clinical manifestations of POEMS. The diagnostic approach is based on different clinical and biological criteria. Patients with a solitary plasmacytoma are candidates for radiotherapy treatment. Patients with diffuse bone involvement or bone marrow infiltration are best treated by systemic drugs. The response to treatment may take several months before clinical and biological improvement. Early diagnosis and dedicated management limit the clinico-functional impact of POEMS.
Collapse
Affiliation(s)
| | - C Bonnet
- Service d'Hématologie, CHU Liège, Belgique
| | - L Lutteri
- Service de Chimie Clinique, CHU Liège, Belgique
| | | | - S Petignot
- Service d'Endocrinologie, CHU Liège, Belgique
| | - I Lievens
- Service de Neurologie, CHU Liège, Belgique
| | - J Caers
- Service d'Hématologie, CHU Liège, Belgique
| |
Collapse
|
30
|
Abstract
Objectif : Cette étude qualitative vise à décrire les effets narratifs d’un protocole d’accompagnement psychooncologique s’appuyant sur les productions picturales d’une proche aidante (Mme Rose, 70 ans) accompagnant son mari atteint d’un cancer incurable.
Matériel et méthode : Il s’agit d’un protocole autour de la figuration picturale de la proche aidante composé de quatre étapes (temps) : l’entretien préliminaire (T1), une première rencontre autour de la création picturale (T2), une seconde rencontre d’approfondissement autour de la création picturale (T3), l’entretien final (T4). Nous avons utilisé le logiciel T-LAB 9.1.3 pour le calcul des associations de mots (cooccurrences) et réalisé une interprétation du récit selon l’approche humaniste/existentielle.
Résultats : Ce dispositif de recherche a permis de montrer les effets narratifs avant et après le travail artistique sur les problématiques psychiques inhérentes au vécu du proche aidant et notamment sur l’angoisse de mort. La dimension romantique du récit semble pouvoir supporter la narration tragique de Mme Rose.
Conclusion : Le « travail psychique avec la production picturale » peut permettre au proche aidant de mettre en figure l’amour et la mort à travers une narration personnelle empruntant à l’univers narratif du romantisme ses enjeux existentiels.
Collapse
|
31
|
Crichi B, Sebuhyan M, Abdallah NA, Montlahuc C, Bonnet C, Villiers S, Maignan CL, Yannoutsos A, Farge D. How to treat venous thromboembolism (TVE) in cancer patients: ten years of multidisciplinary team meetings (MDTM) at Saint-Louis Hospital. J Med Vasc 2020; 45:6S24-6S30. [PMID: 33276940 DOI: 10.1016/s2542-4513(20)30516-2] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/24/2022]
Abstract
BACKGROUND - The management of venous thromboembolism (VTE) is particularly challenging in patients with cancer who undergo complex treatment protocols. Cancer patients often have comorbidities which may affect the efficacy and safety of anticoagulant treatments. Coordinated multidisciplinary management of these complex cases can help optimize delivery of individualized anticoagulant treatment. AIMS - To describe the multidisciplinary team meeting (MDTM) for the management of VTE in cancer patients at our institution and to document outcomes in these patients. METHODS - Bi-monthly MDTMs attended by different physicians and nurses were established at Saint-Louis Hospital in 2008. We performed a retrospective analysis of all cases discussed between September 2008 and January 2018. RESULTS - Over a 10-year period, 520 patients were discussed a total of 551 times. Their mean age was 63 years with 278 (53%) women. The most frequent primary cancer sites were breast (23%), genitourinary (21 %), hematological (20%), digestive (15%), and lung (9%). Fifty-two percent of patients had metastatic cancer, and 54% of them were receiving chemotherapy. The optimal treatment for pulmonary embolism (17%), deep vein thrombosis (16%), catheter-related thrombosis (20%) or combined events (46%) was discussed. Twenty-three patients (4.4%) were discussed for one VTE recurrence and 4 (0.8%) for 2 recurrences. CONCLUSIONS - A dedicated MDTM for the management of VTE in cancer patients allows to discuss a wide range of clinical scenarios and contributes to optimal adherence to evidence-based clinical practices guidelines. The MDTM evaluation was successfully carried out within a short time-frame of VTE diagnosis and helped optimize individualized treatment plans.
Collapse
Affiliation(s)
- B Crichi
- Internal Medicine, Autoimmune and Vascular Disease Unit, Saint-Louis Hospital, Assistance Publique Hôpitaux de Paris, Paris, France; Groupe Francophone Thrombose et Cancer, Paris, France
| | - M Sebuhyan
- Internal Medicine, Autoimmune and Vascular Disease Unit, Saint-Louis Hospital, Assistance Publique Hôpitaux de Paris, Paris, France; Groupe Francophone Thrombose et Cancer, Paris, France
| | - N Ait Abdallah
- Internal Medicine, Autoimmune and Vascular Disease Unit, Saint-Louis Hospital, Assistance Publique Hôpitaux de Paris, Paris, France; Groupe Francophone Thrombose et Cancer, Paris, France
| | - C Montlahuc
- Clinical Research Unit Lariboisière Saint-Louis Hospital, Assistance Publique Hôpitaux de Paris, Paris, France
| | - C Bonnet
- Department of Medical Oncology, Saint-Louis Hospital, Assistance Publique Hôpitaux de Paris, Paris, France
| | - S Villiers
- Groupe Francophone Thrombose et Cancer, Paris, France; Department of Anesthesiology, Saint-Louis Hospital, Assistance Publique Hôpitaux de Paris, Paris, France
| | - C Le Maignan
- Groupe Francophone Thrombose et Cancer, Paris, France
| | - A Yannoutsos
- Department of Vascular Medicine, Paris Saint-Joseph Hospital Group, Paris, France
| | - D Farge
- Internal Medicine, Autoimmune and Vascular Disease Unit, Saint-Louis Hospital, Assistance Publique Hôpitaux de Paris, Paris, France; Groupe Francophone Thrombose et Cancer, Paris, France; Université de Paris, Paris, France; Department of Medicine, McGill University, Montreal, Québec, Canada.
| |
Collapse
|
32
|
Sebuhyan M, Crichi B, Abdallah NA, Bonnet C, Deville L, Marjanovic Z, Farge D. Drug-drug interaction (DDI) with direct oral anticoagulant (DOAC) in patients with cancer. J Med Vasc 2020; 45:6S31-6S38. [PMID: 33276942 DOI: 10.1016/s2542-4513(20)30517-4] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/12/2023]
Abstract
Cancer-associated thrombosis (CAT) is the second leading cause of death in cancer patients after tumor progression. The treatment of CAT is challenging because of a high risk of VTE recurrence, a high risk of bleeding, common presence of comorbidities, poly-medication, and potential drug-drug interactions (DDI). Since 2018, direct oral anticoagulants (DOACs) represent a promising therapeutic alternative and have been recently included into the 2019 update of the International Initiative on Thrombosis and Cancer (ITAC-CME) clinical practice guidelines for management of CAT. However, pharmacokinetic studies suggest that concomitant treatment with P-gp or CYP3A4 inhibitors will result in an increased exposure to rivaroxaban and apixaban, but the clinical relevance of these studies is unknown. In addition, there is an important inter-individual variability in drug absorption, distribution, metabolism and elimination, even more in cancer patients. Overall, the risk of pharmacokinetic DDI should be estimated based on several individual (patient age, renal and liver function, number of comedications) and diseases-related factors, including inflammation, sarcopenia, and low body weight. In this context, DDI with clinical implications could be expected with anti-neoplastic agents or supportive care treatments, especially with drugs known to be moderate or strong inhibitors/inducers of CYP3A4 and P-gp. Consequently, in the presence of potential DDIs through CYP3A4, and/or P-gp, LMWHs remain the first-line anticoagulant of choice for the long-term treatment of CAT. Multidisciplinary consultation meetings and therapeutic patient education should be emphasized in the complex management of CAT.
Collapse
Affiliation(s)
- M Sebuhyan
- Unité de médecine interne : maladies auto-immunes et pathologie vasculaire (UF04), hôpital Saint-Louis, Assistance publique des Hôpitaux de Paris (APHP), 1 avenue Claude-Vellefaux, 75010 Paris, France.
| | - B Crichi
- Unité de médecine interne : maladies auto-immunes et pathologie vasculaire (UF04), hôpital Saint-Louis, Assistance publique des Hôpitaux de Paris (APHP), 1 avenue Claude-Vellefaux, 75010 Paris, France
| | - N Ait Abdallah
- Unité de médecine interne : maladies auto-immunes et pathologie vasculaire (UF04), hôpital Saint-Louis, Assistance publique des Hôpitaux de Paris (APHP), 1 avenue Claude-Vellefaux, 75010 Paris, France
| | - C Bonnet
- Service d'oncologie médicale, hôpital Saint-Louis, Assistance publique des Hôpitaux de Paris (APHP), 1 avenue Claude-Vellefaux, 75010 Paris, France.
| | - L Deville
- Service de pharmacie, hôpital Saint-Louis, Assistance publique des Hôpitaux de Paris (APHP), 1 avenue Claude-Vellefaux, 75010 Paris, France
| | - Z Marjanovic
- Service d'hématologie clinique et thérapie cellulaire, hôpital Saint-Antoine, Assistance publique des Hôpitaux de Paris (APHP), 184 rue du Faubourg Saint-Antoine, 75012 Paris, France
| | - D Farge
- Unité de médecine interne : maladies auto-immunes et pathologie vasculaire (UF04), hôpital Saint-Louis, Assistance publique des Hôpitaux de Paris (APHP), 1 avenue Claude-Vellefaux, 75010 Paris, France; Université de Paris, IRSL, EA-3518, Recherche clinique appliquée à l'hématologie, F-75010 Paris, France; Department of Medicine, McGill University, Montreal, QC, Canada.
| |
Collapse
|
33
|
Jamelot M, Pressat-Laffouilhere T, Baciarello G, Dumont C, Bonnet C, Fizazi K, Culine S. 648P Abiraterone and dexamethasone in castration-resistant prostate cancer: Biological response after switch or rechallenge. Ann Oncol 2020. [DOI: 10.1016/j.annonc.2020.08.907] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022] Open
|
34
|
Abstract
Background Universal antenatal HIV screening programmes are an effective method of preventing mother-to-child transmission. Aims To assess the coverage and yield of the French programme on a nationally representative sample of pregnant women, and predictive factors for being unscreened or missing information on the performance/ result of a HIV test. Methods Data came from the medical records of women included in the cross-sectional 2016 French National Perinatal Survey. We calculated odds ratios (OR) to identify factors for being unscreened for HIV and for missing information by multivariable analyses. Results Of 13,210 women, 12,782 (96.8%) were screened for HIV and 134 (1.0%) were not; information was missing for 294 (2.2%). HIV infection was newly diagnosed in 19/12,769 (0.15%) women screened. The OR for being unscreened was significantly higher in women in legally registered partnerships (OR: 1.3; 95% CI: 1.1–1.6), with 1–2 years of post-secondary schooling (OR: 1.6; 95% CI: 1.2–2.1), part-time employment (OR: 1.4; 95% CI: 1.1–1.8), inadequate antenatal care (OR: 1.9; 95% CI: 1.5–2.4) and receiving care from > 1 provider (OR: 1.8; 95% CI: 1.1–2.8). The OR of missing information was higher in multiparous women (OR: 1.4; 95% CI: 1.2–1.5) and women cared for by general practitioners (OR: 1.4; 95% CI: 1.1–1.9). Conclusions The French antenatal HIV screening programme is effective in detecting HIV among pregnant women. However, a few women are still not screened and awareness of the factors that predict this could contribute to improved screening levels.
Collapse
Affiliation(s)
- Thi-Chiên Tran
- Santé publique France, French national public health agency, Saint-Maurice, France
| | - Josiane Pillonel
- Santé publique France, French national public health agency, Saint-Maurice, France
| | - Françoise Cazein
- Santé publique France, French national public health agency, Saint-Maurice, France
| | - Cécile Sommen
- Santé publique France, French national public health agency, Saint-Maurice, France
| | | | | | - Florence Lot
- Santé publique France, French national public health agency, Saint-Maurice, France
| |
Collapse
|
35
|
Abstract
Uveitis is an inflammation of the uveal tissue: iris, ciliary body and choroid. The annual incidence of uveitis in France is low (17/100,000), but visual and therapeutic consequences may be severe. Etiologic investigation is thus a fundamental step in the management of any uveitis. The history plays an important role in the initial evaluation; it must be methodic. The ophthalmologic examination seeks to classify the uveitis by type (granulomatous or not), location (anterior, intermediate or posterior), severity, duration and recurrence. Systemic signs often orient the diagnosis toward a specific cause. The diagnostic approach to uveitis relies on the history, ophthalmologic examination and evaluation of possible extraocular manifestations. Ancillary testing must be prescribed based on the clinical differential diagnosis, without which their yield is very low.
Collapse
Affiliation(s)
- C Bonnet
- Pôle de Paris, service d'ophtalmologie, hôpital Cochin, université Paris Descartes, 27, rue du Faubourg St Jacques, 75014 Paris, France.
| | - A Brézin
- Pôle de Paris, service d'ophtalmologie, hôpital Cochin, université Paris Descartes, 27, rue du Faubourg St Jacques, 75014 Paris, France
| |
Collapse
|
36
|
Couillard F, Guillain L, Cenraud M, Bertin P, Vergne-Salle P, Bonnet C, Couratier P, Magy L, Fauchais A, Ly K. Une fracture vertébrale non traumatique chez un sujet jeune conduisant au diagnostic de stiff person syndrome ! Rev Med Interne 2019. [DOI: 10.1016/j.revmed.2019.10.279] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
|
37
|
Descamps A, Launay O, Bonnet C, Blondel B. Seasonal influenza vaccine uptake and vaccine refusal among pregnant women in France: results from a national survey. Hum Vaccin Immunother 2019; 16:1093-1100. [PMID: 31725346 DOI: 10.1080/21645515.2019.1688035] [Citation(s) in RCA: 21] [Impact Index Per Article: 4.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/17/2022] Open
Abstract
Pregnant women and infants are at high risk for severe influenza and many countries, including France, recommend annual influenza immunization during pregnancy. We aimed to estimate influenza vaccination and refusal rates and assess associated factors among pregnant women during the 2015-16 season in France. We used data from a national representative sample of women who gave birth in March 2016 and were interviewed before hospital discharge (N = 11,752). In the multivariable analysis, robust Poisson regression models were used to study associations with maternal characteristics and prenatal care characteristics. Influenza vaccine coverage among pregnant women was 7.4% (95% confidence interval [CI]: 6.9-7.9). Only 24.9% (95% CI: 24.2-25.7) of women said that they received a care provider proposal for vaccination and 70.4% (95% CI: 68.7-72.0) of these declined it. Vaccine uptake was associated with low parity (prevalence ratio [PR] = 2.1; 95% CI: 1.4-3.2 for parity 0 vs ≥ 3), high educational level (PR = 2.5; 95% CI: 2.0-3.2), healthcare occupation during pregnancy (PR = 1.8; 95% CI: 1.5-2.1) and preexisting conditions at risk for influenza (PR = 1.7; 95% CI: 1.3-2.2). Women were more frequently vaccinated when their main care provider was a general practitioner. Multiparae women and those with medium or low educational level were significantly more likely than others to decline influenza vaccine after a provider proposal. Influenza vaccine coverage is very low in France, mainly because of infrequent care provider proposals and also frequent women's refusals. Effective interventions should be designed to promote vaccination among medical professionals and reduce vaccine hesitancy among pregnant women.
Collapse
Affiliation(s)
- Alexandre Descamps
- CIC Cochin Pasteur, Hôpital Cochin Broca Hôtel-Dieu, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France
| | - Odile Launay
- CIC Cochin Pasteur, Hôpital Cochin Broca Hôtel-Dieu, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France.,INSERM, CIC 1417, F-CRIN, I-REIVAC, Université de Paris, Paris, France
| | - Camille Bonnet
- Obstetrical, Perinatal and Pediatric Epidemiology Research Team (Epopé), CRESS, INSERM, INRA, Université de Paris, Paris, France
| | - Béatrice Blondel
- Obstetrical, Perinatal and Pediatric Epidemiology Research Team (Epopé), CRESS, INSERM, INRA, Université de Paris, Paris, France
| |
Collapse
|
38
|
Demiguel V, Blondel B, Bonnet C, Andler R, Saurel-Cubizolles MJ, Regnault N. Tobacco smoking in pregnant women: fifty years of evolution in France. Eur J Public Health 2019. [DOI: 10.1093/eurpub/ckz185.438] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Background
Smoking during pregnancy is a major modifiable risk factor for maternal and foetal morbidity. We aimed to describe 1/smoking trends in France between 1972 and 2016, 2/ the factors associated with smoking cessation and reduction during pregnancy in 2016.
Methods
French National Perinatal Surveys are routine surveys based on a representative sample of births (N = 11,733 in 2016). Data were collected in face-to-face interviews in postnatal wards and from the mother’s medical record. Smoking rates before pregnancy and during 3rd trimester were estimated for each study year and characteristics associated with smoking reduction (relative percent change in number of cigarettes smoked before and during pregnancy <50% or ≥ 50%) compared with smoking cessation were analysed using multinomial logistic regression.
Results
After significantly decreasing from 1995 onwards, smoking prevalence stagnates since 2010 both before pregnancy and in the 3rd trimester (30.1% and 16.2%, respectively in 2016). In 2016, 45.8% ceased smoking during pregnancy, 37.2% reduced by ≥ 50% their consumption and 16.9% reduced by < 50% or did not reduce at all. The more cigarettes women smoked before pregnancy, the greater this reduction was (p < 0,001). Moderate reduction (<50%) vs stopping was more frequent in multiparae compared to nulliparae (aOR=2,47 [IC95%:1,93-3,15]) and in women with low education (aOR(<High school vs university graduates)=7,20 [4,78-10,82]) and low income (aOR(<1500€per month/>3000€)=2,30 [1,51-3,50]).
Conclusions
Smoking rates were high before and during pregnancy in France in 2016. Socio-demographic factors should be considered when targeting women most at risk of continuing smoking during pregnancy.
Key messages
After significantly decreasing from 1995 onwards, smoking prevalence stagnates since 2010 both before pregnancy and in the 3rd trimester in France. Supporting female smokers of childbearing age in their attempts to quit and remain non-smokers even after pregnancy is crucial, especially in multiparae and women in poor social condition.
Collapse
Affiliation(s)
- V Demiguel
- Non Communicable Diseases and Trauma Direction, Santé Publique France, St Maurice, France
| | - B Blondel
- INSERM UMR 1153, Obstetrical, Perinatal and Pediatric Epidem, Centre for Epidemiology and Statistics, Paris Descartes University, Paris, France
| | - C Bonnet
- INSERM UMR 1153, Obstetrical, Perinatal and Pediatric Epidem, Centre for Epidemiology and Statistics, Paris Descartes University, Paris, France
| | - R Andler
- Prevention and Health Promotion Direction, Santé Publique France, St Maurice, France
| | - M J Saurel-Cubizolles
- INSERM UMR 1153, Obstetrical, Perinatal and Pediatric Epidem, Centre for Epidemiology and Statistics, Paris Descartes University, Paris, France
| | - N Regnault
- Non Communicable Diseases and Trauma Direction, Santé Publique France, St Maurice, France
| |
Collapse
|
39
|
Bonnet C, Amsallem A, Tissot E, Morgny C, Vandel P. Évaluation de l’utilisation d’antipsychotiques injectables à action prolongée (APAP) versus antipsychotiques per os en vie réelle dans le traitement de la schizophrénie. Rev Epidemiol Sante Publique 2019. [DOI: 10.1016/j.respe.2019.04.032] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022] Open
|
40
|
Morel N, Mehawej H, Bonnet C, Le Guern V, Perard L, Roumier M, Brézin A, Godeau B, Haroche J, Piette J, Costedoat-Chalumeau N. Syndrome catastrophique des antiphospholipides et atteinte du segment postérieur de l’œil. Rev Med Interne 2019. [DOI: 10.1016/j.revmed.2019.03.013] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
41
|
Girault A, Bonnet C, Blondel B, Le Ray C. 307: Decreasing labor intervention rates without increasing cesarean rates: a population-based study in France. Am J Obstet Gynecol 2019. [DOI: 10.1016/j.ajog.2018.11.328] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
42
|
|
43
|
Bonnet C, Blondel B, Piedvache A, Wilson E, Bonamy AKE, Gortner L, Rodrigues C, van Heijst A, Draper ES, Cuttini M, Zeitlin J. Low breastfeeding continuation to 6 months for very preterm infants: A European multiregional cohort study. Matern Child Nutr 2018; 15:e12657. [PMID: 30136374 DOI: 10.1111/mcn.12657] [Citation(s) in RCA: 46] [Impact Index Per Article: 7.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 04/13/2018] [Revised: 06/28/2018] [Accepted: 07/04/2018] [Indexed: 12/16/2022]
Abstract
Breastfeeding confers multiple benefits for the health and development of very preterm infants, but there is scarce information on the duration of breastfeeding after discharge from the neonatal intensive care unit (NICU). We used data from the Effective Perinatal Intensive Care in Europe population-based cohort of births below 32 weeks of gestation in 11 European countries in 2011-2012 to investigate breastfeeding continuation until 6 months. Clinical and sociodemographic characteristics were collected from obstetric and neonatal medical records as well as parental questionnaires at 2 years of corrected age. Among 3,217 ever-breastfed infants, 34% were breastfeeding at 6 months of age (range across countries from 25% to 56%); younger and less educated mothers were more likely to stop before 6 months (adjusted relative risk [aRR] <25 years: 0.68, 95% CI [0.53, 0.88], vs. 25-34 years; lower secondary: 0.58, 95% CI [0.45, 0.76] vs. postgraduate education). Multiple birth, bronchopulmonary dysplasia (BPD), and several neonatal transfers reduced the probability of continuation but not low gestational age, fetal growth restriction, congenital anomalies, or severe neonatal morbidities. Among infants breastfeeding at discharge, mixed versus exclusive breast milk feeding at discharge was associated with stopping before 6 months: aRR = 0.60, 95% CI [0.48, 0.74]. Low breastfeeding continuation rates in this high-risk population call for more support to breastfeeding mothers during and after the neonatal hospitalization, especially for families with low socio-economic status, multiples, and infants with BPD. Promotion of exclusive breastfeeding in the NICU may constitute a lever for improving breastfeeding continuation after discharge.
Collapse
Affiliation(s)
- Camille Bonnet
- INSERM UMR 1153, Obstetrical, Perinatal and Pediatric Epidemiology Research Team (Epopé), Center for Epidemiology and Statistics Sorbonne Paris Cité, DHU Risks in pregnancy, Paris Descartes University, Paris, 75014, France
| | - Béatrice Blondel
- INSERM UMR 1153, Obstetrical, Perinatal and Pediatric Epidemiology Research Team (Epopé), Center for Epidemiology and Statistics Sorbonne Paris Cité, DHU Risks in pregnancy, Paris Descartes University, Paris, 75014, France
| | - Aurélie Piedvache
- INSERM UMR 1153, Obstetrical, Perinatal and Pediatric Epidemiology Research Team (Epopé), Center for Epidemiology and Statistics Sorbonne Paris Cité, DHU Risks in pregnancy, Paris Descartes University, Paris, 75014, France
| | - Emilija Wilson
- Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden
| | - Anna-Karin Edstedt Bonamy
- Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden.,Clinical Epidemiology Unit, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden
| | - Ludwig Gortner
- Department of Neonatology, Pediatric Center, Justus Liebig University Giessen, Giessen, Germany
| | - Carina Rodrigues
- EPIUnit-Instituto de Saúde Pública, Universidade do Porto, Porto, Portugal
| | - Arno van Heijst
- Department of Neonatology, Radboud University Medical Center, Nijmegen, The Netherlands
| | | | - Marina Cuttini
- Clinical Care and Management Innovation Research Area, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy
| | - Jennifer Zeitlin
- INSERM UMR 1153, Obstetrical, Perinatal and Pediatric Epidemiology Research Team (Epopé), Center for Epidemiology and Statistics Sorbonne Paris Cité, DHU Risks in pregnancy, Paris Descartes University, Paris, 75014, France
| | | |
Collapse
|
44
|
Belhadj M, Aquino A, Heng J, Kmiotek S, Raël S, Bonnet C, Lapicque F. Current density distributions in polymer electrolyte fuel cells: A tool for characterisation of gas distribution in the cell and its state of health. Chem Eng Sci 2018. [DOI: 10.1016/j.ces.2018.03.055] [Citation(s) in RCA: 12] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/17/2022]
|
45
|
Arora D, Gérardin K, Raël S, Bonnet C, Lapicque F. Effect of supercapacitors directly hybridized with PEMFC on the component contribution and the performance of the system. J APPL ELECTROCHEM 2018. [DOI: 10.1007/s10800-018-1188-0] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
|
46
|
Fossard G, Broussais F, Coelho I, Bailly S, Nicolas-Virelizier E, Toussaint E, Lancesseur C, Le Bras F, Willems E, Tchernonog E, Chalopin T, Delarue R, Gressin R, Chauchet A, Gyan E, Cartron G, Bonnet C, Haioun C, Damaj G, Gaulard P, Fornecker L, Ghesquières H, Tournilhac O, da Silva MG, Bouabdallah R, Salles G, Bachy E. Role of up-front autologous stem-cell transplantation in peripheral T-cell lymphoma for patients in response after induction: an analysis of patients from LYSA centers. Ann Oncol 2018; 29:715-723. [DOI: 10.1093/annonc/mdx787] [Citation(s) in RCA: 69] [Impact Index Per Article: 11.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
47
|
Baldi I, Engelhardt J, Bonnet C, Bauchet L, Berteaud E, Grüber A, Loiseau H. Epidemiology of meningiomas. Neurochirurgie 2018; 64:5-14. [DOI: 10.1016/j.neuchi.2014.05.006] [Citation(s) in RCA: 72] [Impact Index Per Article: 12.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/19/2014] [Revised: 05/15/2014] [Accepted: 07/24/2014] [Indexed: 12/15/2022]
|
48
|
Bartošová O, Bonnet C, Ulmanová O, Šíma M, Perlík F, Růžička E, Slanař O. Pupillometry as an indicator of l-DOPA dosages in Parkinson’s disease patients. J Neural Transm (Vienna) 2017; 125:699-703. [DOI: 10.1007/s00702-017-1829-1] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/10/2017] [Accepted: 12/12/2017] [Indexed: 11/30/2022]
|
49
|
Morschhauser F, Le Gouill S, Feugier P, Van Den Neste E, Nicolas-Virelizier E, Bijou F, Salles G, Tilly H, Van Eygen K, Van Hoof A, Bonnet C, Haioun C, Bouabdallah R, Fabiani B, Xerri L, Cartron G, Houot R. A PHASE II LYSA STUDY OF OBINUTUZUMAB COMBINED WITH LENALIDOMIDE FOR RELAPSED OR REFRACTORY FOLLICULAR B-CELL LYMPHOMA. Hematol Oncol 2017. [DOI: 10.1002/hon.2437_36] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Affiliation(s)
- F. Morschhauser
- Service des Maladies du Sang; University of Lille; Lille France
| | - S. Le Gouill
- Hematology; Nantes University Hospital; Nantes France
| | - P. Feugier
- Service d'Hématologie; CHU de Nancy - Hôpitaux de Brabois, VANDOEUVRE-LES-NANCY; France
| | - E. Van Den Neste
- Service d'Hématologie; Université Catholique de Louvain Saint Luc; Bruxelles Belgium
| | | | - F. Bijou
- Service d'Hématologie; Institut Bergonié - Centre Régional de Lutte contre le Cancer; Bordeaux France
| | - G.A. Salles
- Service d'Hématologie; CHU Lyon-Sud; Lyon France
| | - H. Tilly
- Service d'Hématologie; Centre Henri Becquerel; Rouen France
| | - K. Van Eygen
- President Kennedylaan 4, AZ Groeninge; Kortrijk Belgium
| | | | - C. Bonnet
- Service d'Hématologie; CHU de Liège; Liège Belgium
| | - C. Haioun
- Unité des Hémopathies Lymphoïdes; Hôpital Henri Mondor; Créteil France
| | - R. Bouabdallah
- Service d'Hématologie; Institut Paoli Calmettes; Marseille France
| | - B. Fabiani
- Service d'Anatomie-Pathologie; Hôpital Saint-Antoine; Paris France
| | - L. Xerri
- Département de Bio-Pathologie; Institut Paoli Calmettes; Marseille France
| | - G. Cartron
- Service d'Hématologie; CHU Saint-Eloi; Montpellier France
| | - R. Houot
- Service d'Hématologie; CHU Pontchaillou; Rennes France
| |
Collapse
|
50
|
Abstract
Vogt-Koyanagi-Harada (VKH) disease is defined as a severe bilateral, chronic granulomatous panuveitis associated with serous retinal detachments, disk edema, and vitritis, with central nervous system, auditory, and integumentary manifestations. It is an autoimmune inflammatory condition mediated by T cells that target melanocytes in individuals genetically susceptible to the disease. Vogt-Koyanagi-Harada disease presents clinically in 4 different phases: prodromal, acute inflammatory, chronic, and recurrent, with extraocular manifestations including headache, meningitis, hearing loss, poliosis, and vitiligo. Optical coherence tomography (OCT) allows earlier diagnosis of VKH disease by revealing heterogeneous exudative detachments of the retina in the acute stage and choroidal thickening, and by demonstrating choroidal thinning in the chronic stage. Treatment of this disease is initially with intravenous corticosteroids, with, if needed, a transition to immunosuppressant drugs for long-term control. Patients with VKH disease can have good final visual outcomes if treated promptly and aggressively.
Collapse
Affiliation(s)
- C Bonnet
- Université Paris Descartes, 75014 Paris, France; Centre Cochin ambulatoire d'ophtalmologie, groupe hospitalier Cochin-Hôtel-Dieu, 27, rue du Faubourg-Saint-Jacques, 75014 Paris, France.
| | - J-B Daudin
- Centre Cochin ambulatoire d'ophtalmologie, groupe hospitalier Cochin-Hôtel-Dieu, 27, rue du Faubourg-Saint-Jacques, 75014 Paris, France
| | - D Monnet
- Université Paris Descartes, 75014 Paris, France; Centre Cochin ambulatoire d'ophtalmologie, groupe hospitalier Cochin-Hôtel-Dieu, 27, rue du Faubourg-Saint-Jacques, 75014 Paris, France
| | - A Brézin
- Université Paris Descartes, 75014 Paris, France; Centre Cochin ambulatoire d'ophtalmologie, groupe hospitalier Cochin-Hôtel-Dieu, 27, rue du Faubourg-Saint-Jacques, 75014 Paris, France
| |
Collapse
|